JP2019166302A - Mixed infusion management system, mixed infusion management program, and mixed infusion management method - Google Patents

Abstract

An object of the present invention is to provide a mixed injection management system, a mixed injection management program, and a mixed injection management method capable of supporting efficient use of a medicine contained in a medicine container. A co-infusion management system performs a co-infusion operation on a plurality of preparation data relating to a co-infusion operation for collecting a medicine and injecting it into an infusion container based on information on a residual medicine generated in a preceding co-infusion operation. The distribution processing unit includes a distribution processing unit that distributes the information to a plurality of co-infusion work units, and a presentation processing unit that presents information on a distribution result obtained by the distribution processing unit. [Selection diagram] FIG.

Description

  The present invention relates to a mixed injection management system, a mixed injection management program, and a mixed injection management method for supporting a mixed injection operation of a medicine such as an anticancer drug.

  There is known a co-infusion apparatus that performs a co-infusion operation in which an anti-cancer drug or the like contained in a drug container such as an ampule or a vial is collected by a syringe and the medicine is injected into an infusion bag containing the infusion solution. (For example, refer to Patent Document 1). In this type of co-infusion apparatus, co-infusion work is performed in a safety cabinet set to a negative pressure in order to prevent exposure to chemicals such as anticancer agents.

JP 2012-250016 A

  By the way, if the amount of the medicine to be collected in the mixed injection operation is not an integral multiple of the amount of the chemical contained in the chemical container, the chemical remains in the chemical container after the mixed injection operation. Therefore, in order to effectively use the remaining medicine remaining in the medicine container, it is conceivable to use the remaining medicine in another mixed injection operation in which the same kind of medicine should be collected.

  However, it is generally not allowed to take a drug container with a drug such as an anticancer drug out of the safety cabinet. Therefore, in a situation where a plurality of safety cabinets are installed, the remaining chemicals generated in the mixed injection operation performed in one safety cabinet cannot be used in the mixed injection operation performed in another safety cabinet. May be wasted.

  An object of the present invention is to provide a mixed injection management system, a mixed injection management program, and a mixed injection management method capable of supporting efficient use of a medicine stored in a medicine container.

  The mixed injection management system according to the present invention includes a plurality of pieces of preparation data relating to a mixed injection operation for collecting and injecting a medicine into an infusion container based on a residual drug generated in the preceding mixed injection operation. A distribution processing unit that distributes to the mixed injection work unit; and a presentation processing unit that presents information related to a distribution result by the distribution processing unit.

  The mixed injection management program according to the present invention provides a plurality of pieces of preparation data relating to a mixed injection operation in which one or a plurality of processors collects a medicine and injects it into an infusion container based on the remaining chemical generated in the preceding mixed injection operation. It is a mixed injection management program for executing a distribution step for distributing to a plurality of mixed injection work units where work is performed and a presentation step for presenting information related to a distribution result in the distribution step.

  The mixed injection management method according to the present invention includes a plurality of pieces of preparation data relating to a mixed injection operation for collecting and injecting a medicine into an infusion container based on a residual drug generated in the preceding mixed injection operation. The distribution step includes a distribution step for distributing to the mixed injection work unit, and a presentation step for presenting information relating to a distribution result in the distribution step.

  ADVANTAGE OF THE INVENTION According to this invention, the mixed injection management system, mixed injection management program, and mixed injection management method which can support the efficient use of the chemical | medical agent accommodated in the chemical | medical agent container are provided.

FIG. 1 is a block diagram showing an example of a mixed injection management system according to an embodiment of the present invention. FIG. 2 is a block diagram showing a system configuration of the co-infusion support apparatus according to the embodiment of the present invention. FIG. 3 is a perspective view showing an external configuration of the co-infusion support apparatus according to the embodiment of the present invention. FIG. 4 is a diagram illustrating a usage state of the safety cabinet used in the mixed injection support device according to the embodiment of the present invention. FIG. 5 is a block diagram showing a system configuration of the automatic co-infusion apparatus according to the embodiment of the present invention. FIG. 6 is a perspective view showing an external configuration of the automatic co-infusion apparatus according to the embodiment of the present invention. FIG. 7 is a perspective view of the automatic co-infusion apparatus according to the embodiment of the present invention with the main door opened. FIG. 8 is a flowchart showing an example of the procedure of the mixed injection management process executed by the mixed injection management system according to the embodiment of the present invention. FIG. 9 is a flowchart showing an example of the procedure of the distribution process executed in the mixed injection management system according to the embodiment of the present invention. FIG. 10 is a diagram illustrating an example of a sorting screen displayed in the mixed injection management system according to the embodiment of the present invention. FIG. 11 is a diagram illustrating an example of a sorting screen displayed in the mixed injection management system according to the embodiment of the present invention. FIG. 12 is a diagram illustrating an example of a sorting screen displayed in the mixed injection management system according to the embodiment of the present invention. FIG. 13 is a diagram illustrating an example of a remaining medicine screen displayed in the mixed injection management system according to the embodiment of the present invention. FIG. 14 is a diagram illustrating an example of a remaining medicine screen displayed in the mixed injection management system according to the embodiment of the present invention. FIG. 15 is a diagram illustrating an example of a remaining medicine screen displayed in the mixed injection management system according to the embodiment of the present invention. FIG. 16 is a block diagram showing a system configuration of the co-infusion support apparatus according to the embodiment of the present invention. FIG. 17 is a perspective view showing an external configuration of the co-infusion support apparatus according to the embodiment of the present invention. FIG. 18 is a perspective view showing an external configuration of a medicine management unit according to the embodiment of the present invention. FIG. 19 is a plan view showing an external configuration of a medicine management unit according to the embodiment of the present invention. FIG. 20 is a flowchart showing an example of the procedure of the remaining medicine storage process executed in the mixed injection management system according to the embodiment of the present invention. FIG. 21 is a diagram showing an example of remaining medicine management information used in the mixed injection management system according to the embodiment of the present invention. FIG. 22A is a diagram for explaining a notification method in the medicine management unit according to the embodiment of the present invention. FIG. 22B is a diagram for explaining a notification method in the medicine management unit according to the embodiment of the present invention. FIG. 22C is a diagram for explaining a notification method in the medicine management unit according to the embodiment of the present invention. FIG. 22D is a diagram for explaining a notification method in the medicine management unit according to the embodiment of the present invention. FIG. 23 is a flowchart illustrating an example of a procedure of residual drug use processing executed in the mixed injection management system according to the embodiment of the present invention. FIG. 24 is a flowchart illustrating an example of a procedure of residual drug use processing executed in the mixed injection management system according to the embodiment of the present invention. FIG. 25A is a diagram illustrating an example of a guidance screen displayed in the mixed injection management system according to the embodiment of the present invention. FIG. 25B is a diagram illustrating an example of a guidance screen displayed in the mixed injection management system according to the embodiment of the present invention. FIG. 26A is a diagram illustrating an example of a registration screen displayed in the mixed injection management system according to the embodiment of the present invention. FIG. 26B is a diagram showing an example of a registration screen displayed in the mixed injection management system according to the embodiment of the present invention. FIG. 27 is a diagram showing an example of a setting screen displayed in the mixed injection management system according to the embodiment of the present invention. FIG. 28 is a diagram illustrating an example of a form output by the mixed injection management system according to the embodiment of the present invention. FIG. 29 is a diagram showing an example of an output screen displayed in the mixed injection management system according to the embodiment of the present invention.

  Hereinafter, embodiments of the present invention will be described with reference to the accompanying drawings for understanding of the present invention. The following embodiment is an example embodying the present invention, and does not limit the technical scope of the present invention.

  As shown in FIG. 1, a mixed injection management system 1 according to an embodiment of the present invention includes a mixed injection management device 2, one or a plurality of client terminals 3, one or a plurality of mixed injection support devices 4, and one or a plurality of components. And an automatic co-infusion apparatus 5. Here, the mixed injection management system 1 is an example of a mixed injection management system according to the present invention. The mixed injection management device 2 alone may be regarded as a mixed injection management system according to the present invention. Further, the mixed injection support device 4 alone may be regarded as a mixed injection management system according to the present invention.

  Each of the mixed injection management device 2, the client terminal 3, the mixed injection support device 4, and the automatic mixed injection device 5 is connected to be communicable wirelessly or by wire via a communication network N1 such as a LAN or the Internet. The mixed injection management apparatus 2 is connected to a host system 6 such as an electronic medical record system or a prescription input terminal for inputting prescription data to the mixed injection management apparatus 2 via the communication network N1. For example, the prescription data includes prescription delivery date, patient ID, patient name, patient birth date, drug information (drug code, drug name, dose, etc.), taking method (internal use, external use, etc.), usage information ( 3 times a day after every meal, etc.), medical treatment type (outpatient, hospitalization, etc.), clinical department, ward, and hospital room. It is also conceivable that the mixed injection management device 2 can read prescription data from a prescription or that the mixed injection management device 2 can input prescription data by a user operation.

[Mixed injection management device 2]
The mixed injection management device 2 is a personal computer including a control unit 21, a storage unit 22, a communication I / F 23, a display unit 24, an operation unit 25, a drive device 26, and the like. The mixed injection management device 2 is arranged inside or outside a medical institution where the mixed injection management system 1 is used.

  The control unit 21 includes control devices such as a CPU, a ROM, a RAM, and an EEPROM (registered trademark, hereinafter the same). The CPU is a processor that executes various arithmetic processes. The ROM is a non-volatile storage unit in which information such as a control program for causing the CPU to execute various processes is stored in advance. The RAM is a volatile storage unit, and the EEPROM is a non-volatile storage unit. The RAM and the EEPROM are used as a temporary storage memory (working area) for various processes executed by the CPU. And the said control part 21 performs various processes according to the various control programs (for example, mixed injection management program mentioned later) previously stored in the said ROM, the said EEPROM, or the said memory | storage part 22 using the said CPU. .

  The storage unit 22 is a storage unit such as an HDD (Hard Disk Drive) or an SSD (Solid State Drive) that stores various data. Specifically, the storage unit 22 stores in advance a mixed injection management program for causing a computer such as the control unit 21 to execute a mixed injection management process (see FIG. 8) described later. The present invention may be understood as an invention of the mixed injection management program for causing the computer such as the control unit 21 to execute the mixed injection management process or a computer-readable recording medium recording the mixed injection management program. The present invention may also be understood as an invention of a mixed injection management method for executing each processing procedure of the mixed injection management process in the mixed injection management device 2 or the like.

  The storage unit 22 also stores various databases such as a pharmaceutical master, a patient master, and a user master. Further, the storage unit 22 stores a drug database separately from the drug master.

  The medicine master includes medicine ID, medicine code, medicine name, YJ code, JAN code (or RSS code), medicine bottle code, classification (dosage form: powder, tablet, liquid medicine, topical medicine, etc.), tablet shape (Capsule tablets, spherical tablets, flat tablets (disc-shaped tablets), etc.), tablet color, tablet size, specific gravity, chemical type (ordinary drugs, poisonous drugs, narcotics, powerful drugs, antipsychotics, therapeutic drugs, etc.), Contains information on each drug, such as formulation changes, excipients, and precautions.

  The user master includes information about the user such as a pharmacy name, a pharmacist name, a pharmacist ID, a password, a user group, and processing authority. The patient master includes information about the patient such as patient ID, name, sex, age, medical history, prescription drug history, family information, medical department, ward, and hospital room.

  For each drug, drug code, drug name, JAN code, RSS code, drug bottle code, dosage form, unit, specific gravity, drug type, formulation change, excipient, allergy information, attached to the drug database Information such as document information is stored in association with each other. In particular, in the drug database, for the tablet, information such as the identification information of the tablet formed on the tablet (for example, information for identifying the drug type of the tablet) and the shape of the tablet are stored. The medicine database is read from a recording medium such as a CD or a DVD by the drive device 26, or received from an external device via the communication network N1, and stored in the storage unit 22. The drug database is used in the mixed injection management system 1 when information is taken into various masters such as the drug master, or when referring to the information on the package insert of each drug. Moreover, the structure which can read the said chemical | medical agent database from the external apparatus or website via the said communication network N1 as needed may be sufficient. The drug database is used for updating the drug master.

  The communication I / F 23 is wirelessly or wired between the client terminal 3, the co-infusion support apparatus 4, and the automatic co-infusion apparatus 5 via the communication network N1 according to a predetermined communication protocol. A communication interface having a network card or the like for executing data communication.

  The display unit 24 is a display unit such as a liquid crystal monitor that displays various types of information and operation screens in accordance with control instructions from the control unit 21. The operation unit 25 is an operation unit such as a keyboard, a mouse, and a touch panel that accepts a user operation, and inputs an operation signal corresponding to the user operation to the control unit 21. The operation unit 25 receives various operation inputs such as a prescription data selection operation on the display screen displayed on the display unit 24 and a prescription data issuing operation for requesting the start of dispensing of the prescription data.

  The drive device 26 can read the mixed injection management program from a computer-readable recording medium 261 in which the mixed injection management program is recorded. The recording medium 261 is a CD, DVD, BD, USB memory, or the like, and the drive device 26 is a CD drive, DVD drive, BD drive, USB port, or the like. In the mixed injection management device 2, the mixed injection management program read from the recording medium 261 using the drive device 26 is stored in the storage unit 22 by the control unit 21.

  In the mixed injection management device 2 configured as described above, the control unit 21 executes various processes according to the mixed injection management program. The control unit 21 generates prescription data (hereinafter referred to as preparation data) indicating the contents of the mixed injection operation described below based on the prescription data, and the preparation data is used as the mixed injection support device 4 and the automatic mixed injection. It also has a function of inputting to the device 5. Thereby, in the mixed injection support device 4 and the automatic mixed injection device 5, a mixed injection support process and an automatic mixed injection process which will be described later are executed based on the preparation data.

  For example, the preparation data includes patient information (patient ID, patient name, height, weight, body surface area, etc.), preparation date, preparation time, drug information (drug code, drug name, etc.), and dose (drug dispensing amount). , And regimen identification information. The regimen identification information is information that can identify regimen information such as a therapy name (regimen name), a therapy ID, or a regimen ID. In addition, the preparation data includes doctor information, type of chemical container (such as ampoules containing chemicals, vials containing chemicals, or vials containing powders), preparation information (such as chemical containers, syringes, and needles used for mixed injection). Type, number, etc.), and preparation procedure information (work contents, dissolved drug, solvent, dissolved drug volume, solvent volume, sampling volume), information such as medication date, prescription category, clinical department, ward, etc. . Further, the preparation data may be the prescription data itself.

  The control unit 21 displays the result of the mixed injection management process executed based on the preparation data on the client terminal 3 or the like. Details of the mixed injection management process executed by the control unit 21 will be described later.

[Client terminal 3]
The client terminal 3 is a personal computer including a control unit 31, a storage unit 32, a communication I / F 33, a display unit 34, an operation unit 35, and the like. Each of the client terminals 3 is an operation terminal that is disposed in a medical institution where the mixed injection management system 1 is used and is operated by a user such as a pharmacist.

  The control unit 31 includes control devices such as a CPU, a ROM, a RAM, and an EEPROM. The CPU is a processor that executes various arithmetic processes. The ROM is a non-volatile storage unit in which information such as a control program for causing the CPU to execute various processes is stored in advance. The RAM is a volatile storage unit, and the EEPROM is a non-volatile storage unit. The RAM and the EEPROM are used as a temporary storage memory (working area) for various processes executed by the CPU. And the said control part 31 performs various processes according to the various control programs previously stored in the said ROM, the said EEPROM, or the said memory | storage part 32 using the said CPU.

  The storage unit 32 is a non-volatile storage unit such as a hard disk or an SSD in which various application programs executed by the control unit 31 and various data are stored. Specifically, the storage unit 32 stores an operating system (OS) and application programs such as browser software. The browser software displays the various operation screens on the display unit 34 by accessing the mixed injection management device 2 via the communication network N1, and performs an input operation on the operation screen using the operation unit 35. Is the application software for transmitting to the mixed injection management device 2. Specifically, when address information such as a URL (Universal Resource Locator) corresponding to the mixed injection management device 2 is input at a predetermined position on the operation screen displayed by the browser software, the control unit 31 The mixed injection management device 2 is accessed based on the address information.

  The communication I / F 33 is a communication having a network card or the like for performing data communication wirelessly or by wire according to a predetermined communication protocol with an external device such as the mixed injection management device 2 via the communication network N1. Interface.

  The display unit 34 is a display unit such as a liquid crystal display or an organic EL display that displays various types of information in accordance with control instructions from the control unit 31. The operation unit 35 is an operation unit operated by a user in order to input various information to the client terminal 3. Specifically, the operation unit 35 includes a keyboard that receives input operations on various operation screens displayed on the display unit 34, a mouse (pointing device), and a touch panel.

  In the mixed injection management system 1, a server client system is configured by the mixed injection management device 2 and the client terminal 3, and the mixed injection management device 2 executes various processes according to user operations of the client terminal 3. To do. For example, the control unit 21 of the mixed injection management device 2 displays various screens on the display unit 34 of the client terminal 3 by transmitting data described in a page description language such as HTML to the client terminal 3. . In addition, the control unit 31 of the client terminal 3 transmits an operation signal to the mixed injection management device 2 in response to an operation input to the operation unit 35.

  A part or all of the mixed injection management program is installed in any one or a plurality of the mixed injection management device 2, the client terminal 3, and the mixed injection support device 4, and a mixed injection management process (see FIG. 8) may be executed in cooperation by the mixed injection management device 2, the client terminal 3, the mixed injection support device 4, or the like.

[Mixed injection support device 4]
Next, the configuration of the mixed injection support device 4 will be described with reference to FIGS. As shown in FIGS. 2 and 3, the mixed injection support device 4 includes a control unit 41, an operation display unit 42, a first reading unit 43, a printer 44, a foot switch unit 45, a second reading unit 46, and a weighing unit 47. Etc. The mixed injection support device 4 is used to improve the efficiency of mixed injection work performed by an operator such as a doctor or a pharmacist.

  The mixed injection operation is an operation of injecting a medicine (drug, preparation) such as an anticancer agent shown in the preparation data from one or a plurality of medicine containers containing a predetermined amount of the medicine into an infusion container. Specifically, in the mixed injection operation, an operator may perform an operation of sucking a drug solution from a drug container with a syringe and injecting the solution into an infusion bag containing a solution such as physiological saline. Further, in the mixed injection work, an operator sucks a solution such as a physiological saline solution from an infusion bag with a syringe, and injects the solution into a medicine container in which the powder is contained, dissolves the powder, and after the dissolution In some cases, the chemical solution is sucked with a syringe and injected into an infusion bag.

  As shown in FIG. 3, the second reading unit 46 and the weighing unit 47 are disposed in a work chamber 101 of a safety cabinet 100 where an operator performs mixed injection work. On the other hand, the control unit 41, the operation display unit 42, the first reading unit 43, the printer 44, and the foot switch unit 45 are disposed outside the work room of the safety cabinet 100. The operation display unit 42 and the printer 44 may be provided in the work chamber 101 of the safety cabinet 100.

  The safety cabinet 100 or the work chamber 101 is an example of the mixed injection work unit of the present invention. The safety cabinet 100 or the work chamber 101 is also an example of a manual operation unit according to the present invention.

  The safety cabinet 100 includes a work chamber 101 partitioned by a glass door 102 having a transparent front surface. The glass door 102 is supported at a position where an opening 103 is formed below, and an operator can access the work chamber 101 from the opening 103. The safety cabinet 100 is also provided with an air cleaning device 104 having a HEPA filter for purifying and exhausting the air in the work chamber 101.

  Then, as shown in FIG. 4, the operator inserts both hands into the work chamber 101 from the opening 103 and performs a chemical injection operation while visually observing the inside of the work chamber 101. In the mixed injection support device 4, when a non-toxic chemical (medicine, preparation) is mixed, a clean bench or the like may be used instead of the safety cabinet 100. The work room of the clean bench is also an example of the mixed injection work unit of the present invention.

  The second reading unit 46 provided in the safety cabinet 100 is a code reading device capable of reading code information such as a one-dimensional code or a two-dimensional code attached to a medicine container for a medicine used in the mixed injection operation. is there. The two-dimensional code is, for example, a QR code (registered trademark). The code information includes identification information for specifying the type of the medicine. The code information read by the second reading unit 46 is input to the control unit 41.

  Similarly, the weighing unit 47 provided in the safety cabinet 100 is an electronic balance used for various types of weighing in the mixed injection work. The measurement result by the weighing unit 47 is input to the control unit 41 in real time. Further, the weighing unit 47 inputs stability information indicating whether or not the measurement result is stable to the control unit 41. Thereby, in the said control part 41, it is possible to acquire information, such as the measurement result by the said weighing | measuring part 47, and the presence or absence of stability. The control unit 41 may be configured to actively read information such as a measurement result obtained by the weighing unit 47 and the presence or absence of stability.

  The control unit 41 is communicably connected to the mixed injection management device 2 via the communication network N1 in a wireless or wired manner. The control unit 41 can acquire the preparation data from the mixed injection management device 2.

  The control unit 41 is a computer having a CPU 411, a RAM 412, a storage unit 413, and the like. The CPU 411 is a processor that executes various arithmetic processes. The RAM 412 is a volatile storage unit, and is used as a temporary storage memory (working area) for various processes executed by the CPU 411. The storage unit 413 is a non-volatile storage unit such as an HDD or an SSD in which information such as a control program for causing the CPU 411 to execute various processes is stored. The control unit 41 uses the CPU 411 and the RAM 412 to execute various processes according to various control programs stored in advance in the storage unit 413.

  The storage unit 413 includes storage areas such as a data area, a program area, and a master area. The storage unit 413 may include a plurality of storage media such as an HDD and a semiconductor memory, and the data area, the program area, and the master area may be distributed and provided in a plurality of storage media. .

  In the data area, the preparation data acquired from the mixed injection management device 2 is accumulated and stored. The control unit 41 can also newly register or edit the preparation data according to a user operation. In the data area, history data indicating the contents of mixed injection work performed by an operator according to the preparation data is stored in association with the preparation data. For example, the history data includes a worker of the mixed injection work, a work start time, a work end time, and a photographed image taken during the mixed injection work.

  In the program area, a control program for causing the control unit 41 to execute a mixed injection support process, which will be described later, is stored. Note that an application program such as an operating system (OS) and browser software is also stored in the program area.

  The master area stores various types of master information such as a pharmaceutical master, a patient master, a ward master, a doctor master, and a pharmacist master. For example, the medicine master includes medicine ID, medicine name, medicine code, medicine bottle code, classification (dosage form: powder, tablet, liquid medicine, topical medicine, etc.), specific gravity, medicine type (ordinary medicine, anticancer drug) , Poisonous drugs, narcotics, powerful drugs, antipsychotics, therapeutic drugs, etc.), formulation changes, excipients, precautions, types of drug containers (ampoules, vials), drug capacity per drug container (predetermined amount), And information such as the weight of the chemical container. The medicine ID is an identification code such as a YJ code, JAN code, or RSS code.

  The operation display unit 42 is a display unit such as a liquid crystal display or an organic EL display that displays various types of information in accordance with control instructions from the control unit 41, and is operated by a user to input various types of information to the control unit 41. An operation unit.

  Specifically, the operation unit of the operation display unit 42 is a touch panel that receives touch operations on various operation screens displayed on the display unit. The operation display unit 42 may be a tablet terminal. The operation unit may include a keyboard and a mouse (pointing device) that accept input operations on various operation screens displayed on the display unit. Furthermore, the operation unit may include a voice input device that receives input of various types of information by voice recognition.

  The first reading unit 43 is a code reading device capable of reading code information such as a one-dimensional code or a two-dimensional code printed on a preparation note (dispensing instruction) corresponding to the preparation data. The code information includes identification information for identifying the preparation data. The code information read by the first reading unit 43 is input to the control unit 41. And the said control part 41 specifies the said preparation data used as the object of this mixed injection work based on the said code information read from the said preparation note using the said 1st reading part 43. FIG. Specifically, the control unit 41 reads identification information of the preparation data from the code information, and selects the preparation data corresponding to the identification information from the data area of the storage unit 413. The control unit 41 may acquire the preparation data from the code information.

  The printer 44 is used by the control unit 41 to print various information. For example, it is used for printing the preparation note corresponding to the preparation data executed by the control unit 41, or printing history data of the mixed injection work executed according to the preparation data. The printer 44 is used for printing a remaining medicine authentication label including the contents of the remaining medicine (residual medicine) generated in the mixed injection operation, a one-dimensional code or a two-dimensional code indicating the contents of the remaining medicine.

  The foot switch unit 45 is an operation unit for an operator to input an operation to the control unit 41 during execution of the mixed injection work. The foot switch unit 45 includes a first foot switch 451, a second foot switch 452, and a third foot switch 453. The first foot switch 451 and the second foot switch 452 are used for selecting an operation target item, and the third foot switch 453 is used for determining an operation target item.

  Note that, in the mixed injection work, by an operator, for example, a chemical authentication process, a tare drawing process, a dissolution liquid extraction process, a dissolution liquid measurement process, a dissolution liquid imaging process, a dissolution process, a chemical extraction process, a chemical measurement process, a chemical imaging process, In addition, a necessary work process is selected from the mixed injection process and the like and sequentially executed.

  The medicine authentication process is a process for authenticating a medicine used in the mixed injection operation, and is a process of reading medicine identification information using the second reading unit 46, for example. The taring process is a process for measuring in advance the weight of only a device such as a syringe used in the mixed injection operation, for example, a process of placing the syringe on the weighing unit 47.

  The solution extraction step is a step of extracting a necessary amount of a solution such as physiological saline from an infusion bag with a syringe. The solution measuring step is a step for measuring the weight of the syringe from which the solution has been extracted, and is a step for placing the syringe on the weighing unit 47. In the dissolution liquid measuring step, the control unit 41 sets the difference between the weight of the syringe placed on the weighing unit 47 and the weight of the syringe set by the taring as the weight of the dissolution liquid. Weigh. The solution photographing step is a step for photographing the syringe from which the solution has been extracted with a photographing unit (not shown). The dissolution step is a step for dissolving the drug when the drug is a powder drug, and is a step of injecting the solution extracted with the syringe into the drug container.

  The said chemical | medical solution extraction process is a process of extracting a chemical | medical solution from a chemical | medical agent container with a syringe. The medicinal solution measuring step is a step for measuring the weight of the syringe from which the medicinal solution has been extracted, and is a step of placing the syringe on the weighing unit 47. Also in the chemical solution measurement step, the control unit 41 measures the difference between the weight of the syringe placed on the weighing unit 47 and the weight of the syringe set by the tare as the weight of the chemical solution. To do. The chemical liquid photographing step is a step for photographing the syringe from which the chemical liquid has been extracted with the photographing unit. The mixed injection step is a step of injecting the drug solution in the syringe into the infusion bag.

  The control unit 41 executes mixed injection support processing based on a control program stored in the storage unit 413. In the mixed injection support process, the control unit 41 causes the operation display unit 42 to sequentially display work steps necessary for the mixed injection work based on the preparation data to be subjected to the mixed injection work. Thereby, the operator can advance the said work process in order according to the display.

[Automatic co-infusion device 5]
Next, the configuration of the automatic co-infusion apparatus 5 will be described with reference to FIGS. As shown in FIG. 5, the automatic co-infusion apparatus 5 includes a control unit 51, a medicine loading unit 54, and a co-infusion processing unit 55. In the automatic co-infusion apparatus 5, when the operation of the co-infusion processing unit 55 is controlled by the control unit 51, a predetermined amount of a medicine (medicine, formulation) such as an anticancer agent indicated in the preparation data is supplied An automatic co-infusion process for injecting the medicine from one or a plurality of medicine containers containing the medicine into the infusion container is executed.

  The control unit 51 includes a first control unit 52 and a second control unit 53 connected so as to be capable of bidirectional communication via a communication network such as a LAN or the Internet (for example, the communication network N1). The first control unit 52 is provided on the medicine loading unit 54 side, and the second control unit 53 is provided on the mixed injection processing unit 55 side. The first control unit 52 is connected to the mixed injection management device 2 via the communication network N1, and the preparation data is input from the mixed injection management device 2 to the first control unit 52. .

  The first control unit 52 is a personal computer including a CPU 521, a ROM 522, a RAM 523, a data storage unit 524, an operation unit 525, and the like. Various electrical components such as a display 541, a barcode reader 542, and an air cleaning device 543, which will be described later, provided in the medicine loading unit 54 are connected to the first control unit 52.

  The CPU 521 is a processor that executes processing according to various control programs. The ROM 522 is a nonvolatile memory in which programs such as BIOS executed by the CPU 521 are stored in advance. The RAM 523 is a volatile memory or a non-volatile memory used for development of various control programs and temporary storage of data by the CPU 521.

  The data storage unit 524 is a hard disk or the like that stores various application programs executed by the CPU 521 and various data. Specifically, the preparation data input from the mixed injection management device 2 is stored in the data storage unit 524. The data storage unit 524 stores various databases such as a pharmaceutical master, a patient master, a doctor master, a prescription category master, a clinical department master, and a ward master. For example, the medicine master includes medicine code, medicine name, JAN code (or RSS), medicine bottle code, classification (dosage form: powder, tablet, liquid medicine, topical medicine, etc.), specific gravity, kind of medicine (ordinary medicine, Anticancer drugs, poisons, narcotics, powerful drugs, antipsychotics, therapeutic drugs, etc.), compounding changes, excipients, precautions, types of drug containers (ampoules, vials), drug capacity per drug container ( Information such as the default amount). Below, the information which shows the chemical | medical agent accommodation amount (predetermined amount) of a chemical | medical agent container unit is called predetermined amount information. In the pharmaceutical master, when a plurality of types of medicine containers exist for the same medicine, predetermined amount information corresponding to each medicine container is stored.

  The operation unit 525 includes various operation means such as a keyboard, a mouse, or a touch panel that receives various user operations in the first control unit 52.

  The second control unit 53 is a personal computer including a CPU 531, a ROM 532, a RAM 533, a data storage unit 534, an operation unit 535, and the like. Various electrical components such as a first robot arm 551, a second robot arm 552, and a container transfer unit 553, which will be described later, provided in the mixed injection processing unit 55 are connected to the second control unit 53.

  The CPU 531 is a processor that executes processing according to various control programs. The ROM 532 is a non-volatile memory in which programs such as BIOS executed by the CPU 531 are stored in advance. The RAM 533 is a volatile memory or a non-volatile memory used for development of various control programs and temporary storage of data by the CPU 531.

  The data storage unit 534 is a hard disk or the like that stores various application programs executed by the CPU 531 and various data. For example, the data storage unit 534 stores in advance a control program for controlling the mixed injection processing unit 55.

  The operation unit 535 includes various operation means such as a keyboard, a mouse, or a touch panel that receives various user operations in the second control unit 53.

  As shown in FIGS. 6 and 7, the medicine loading unit 54 is a clean bench including a display 541, a barcode reader 542, and an air cleaning device 543. As shown in FIG. 7, the medicine loading unit 54 and the mixed injection processing unit 55 are communicated with each other through a communication opening 201 formed on a side surface of the mixed injection processing unit 55.

  The display 541 is a display unit such as a liquid crystal display or an organic EL display that displays various types of information in response to a control instruction from the first control unit 52. Specifically, the display 541 displays preparation data and the like to be subjected to automatic co-infusion processing in the automatic co-infusion apparatus 5. The bar code reader 542 reads a bar code written on a prescription or a preparation instruction, and inputs the content of the bar code to the first control unit 52. The air cleaning device 543 supplies air through the predetermined filter into the medicine loading unit 54.

  As shown in FIG. 6, the user performs a preparatory work for the automatic co-infusion process executed by the automatic co-infusion apparatus 5 with the hand placed in the medicine loading unit 54. Specifically, in the preparatory work, for example, a medicine container (ampoule, vial, etc.), a syringe, and an infusion bag are placed in a predetermined position of the container 202, and the container 202 is loaded into the mixed injection processing unit 55. Includes loading operations.

  The container 202 is supplied to the mixed injection processing unit 55 through the communication opening 201 after the medicine container, the syringe, and the infusion bag are set by the user.

  As shown in FIG. 6, a main door 200 is provided in front of the mixed injection processing unit 55. The main door 200 is opened and closed to access the mixed injection processing chamber 203 when, for example, cleaning the mixed injection processing chamber 203 provided in the mixed injection processing unit 55.

  The mixed injection processing unit 55 is provided with a garbage storage chamber 204 that stores waste such as the medicine container and the syringe after being used in the automatic mixed injection processing in the mixed injection processing chamber 203.

  As shown in FIG. 7, the mixed injection processing chamber 203 is provided with a first robot arm 551, a second robot arm 552, a container transfer section 553, and the like having an articulated structure. The mixed injection processing chamber 203 is provided with an ampoule cutter, a stirrer, a mounting shelf, a chemical reading unit, a weighing meter, a mixed injection communication port 205, a dust cover, a plurality of cameras, a germicidal lamp, and the like.

  The automatic co-infusion apparatus 5 or the co-infusion processing chamber 203 is an example of the co-infusion operation unit of the present invention. The automatic co-infusion apparatus 5 or the co-infusion processing chamber 203 is also an example of an automatic operation unit according to the present invention.

  In the automatic co-infusion apparatus 5, co-infusion is performed by the double-arm first robot arm 551 and the second robot arm 552. Specifically, the second control unit 53 controls the first robot arm 551 and the second robot arm 552 to cause the first robot arm 551 and the second robot arm 552 to perform the mixed injection operation. . The mixed injection processing unit 55 has a structure capable of executing the automatic mixed injection processing, for example, a configuration having one robot arm, a configuration including three or more robot arms, or a robot arm is not used. It may be a configuration.

  Further, the mixed injection processing unit 55 is provided with a container transfer unit 553 that transfers the container 202 supplied from the communication opening 201. The chemical containers (ampoules, vials, etc.) and syringes placed on the container 202 are transferred to the mixed injection processing chamber 203 by the container transfer unit 553. The infusion bag placed on the container 202 is transported by the container transport unit 553 and is held in a state where the mixed injection port of the infusion bag is located at the mixed injection communication port 205.

  The ampoule cutter can fold the head of the ampoule.

  The stirring device can stir the vial. When the powder is stored in the vial, the agitator is used when injecting an infusion or a drug into the vial to dissolve the powder and generating a mixed drug.

  The placement shelf is used for temporarily placing the medicine container, the syringe, and the like in the automatic co-infusion process executed in the automatic co-infusion apparatus 5. Further, the shelf described above is also used as a standby position for waiting the medicine container when medicine remains in the medicine container after the automatic co-infusion process is executed. Of course, the standby position may be provided at a position different from the placement shelf.

  The medicine reading unit is capable of reading a barcode indicating information on the contained medicine described on a label attached to the medicine container such as the ampule or the vial.

  The weigh scale is used to measure the weight of the syringe in the automatic co-infusion process executed in the automatic co-infusion apparatus 5, and the measurement result by the weigh scale is input to the second control unit 53. Thereby, the second control unit 53 calculates the difference between the weight of the syringe after the medicine is sucked from the medicine container and the known weight of the syringe itself, for example, and thereby the medicine liquid sucked from the medicine container The amount can be acquired.

  The mixed injection communication port 205 is formed in the side wall of the mixed injection processing chamber 203 as shown in FIG. The infusion bag is held in a state where only the mixed injection port of the infusion bag is located in the mixed injection processing chamber 203 through the mixed injection communication port 205.

  The sterilization lamp is turned on, for example, 3 hours before the start of the automatic co-infusion processing, and sterilizes the inside of the co-infusion processing chamber 203.

  The mixed injection processing unit 55 sucks the air in the mixed injection processing chamber 203 through a slit 206 (see FIG. 7) formed in the lower part of the side wall of the mixed injection processing chamber 203 and above the mixed injection processing chamber 203. There is provided an exhaust system for exhausting from an exhaust fan (not shown). The mixed injection processing unit 55 is also provided with an air supply system that cleans the outside air from an intake port formed in the ceiling of the mixed injection processing chamber 203 and guides it to the mixed injection processing chamber 203 and the like.

  In the automatic co-infusion process executed in the automatic co-infusion apparatus 5, the first robot arm 551, the second robot arm 552, and the like are controlled by the second control unit 53, and are indicated in the preparation data. A drug such as an anticancer drug is injected into the infusion bag from one or a plurality of the drug containers in which a predetermined amount of the drug is stored.

  By the way, if the amount of the medicine to be collected in the mixed injection operation is not an integral multiple of the amount of the chemical contained in the chemical container, the chemical remains in the chemical container after the mixed injection operation. Therefore, in order to effectively use the remaining medicine remaining in the medicine container, it is conceivable to use the remaining medicine in another mixed injection operation in which the same kind of medicine should be collected. However, it is generally not allowed to take a drug container with a drug such as an anticancer drug out of the safety cabinet. Therefore, in a situation where a plurality of safety cabinets are installed, the remaining chemicals generated in the mixed injection operation performed in one safety cabinet cannot be used in the mixed injection operation performed in another safety cabinet. May be wasted. On the other hand, in the mixed injection management system 1 according to the present embodiment, it is possible to support efficient use of the medicine stored in the medicine container.

  In the present embodiment, as the mixed injection operation unit for performing the mixed injection operation, three mixed injection operation units including the two safety cabinets 100 and the one automatic mixed injection device 5 are provided. The mixed injection support device 4 is provided. Hereinafter, one of the two safety cabinets may be referred to as “safety cabinet 1” and the other may be referred to as “safety cabinet 2”. The automatic co-infusion apparatus 5 may be referred to as “chemo”. “Safety cabinet 1” and “safety cabinet 2” are examples of a manual operation unit in which the mixed injection operation is performed by a person, and “Chemoro” is an example of an automatic operation unit in which the mixed injection operation is performed by a robot.

  In the mixed injection management apparatus 2, the control unit 21 can execute a mixed injection management process for distributing a plurality of the preparation data corresponding to the mixed injection operation to be performed to the three mixed injection operation units.

  As shown in FIG. 1, the control unit 21 of the mixed injection management device 2 includes a distribution processing unit 211, a presentation processing unit 212, a remaining amount calculation processing unit 213, and a remaining amount management processing unit 214. Specifically, the control unit 21 executes various processes in accordance with the mixed injection management program stored in the storage unit 22 to thereby distribute the distribution processing unit 211, the presentation processing unit 212, the remaining amount calculation processing unit 213, and It functions as the remaining amount management processing unit 214.

  The distribution processing unit 211 has a plurality of preparation data related to a mixed injection operation in which a chemical is collected from one or a plurality of chemical containers containing a predetermined amount of chemical and injected into an infusion container. Based on information related to medicine (for example, presence / absence, type, amount, usable period, etc. of the remaining medicine), the medicine is distributed to a plurality of independent co-working units where the co-working work is performed. In the mixed injection management device 2, the information on the remaining medicines that the distribution processing unit 211 considers when distributing the preparation data is the residual medicine generated in the mixed injection work based on each of the preparation data to be distributed. It is not limited to information. For example, the distribution processing unit 211 may receive residual drug management information described later from the co-infusion support apparatus 4 and distribute the preparation data in consideration of the residual drug management information. Specifically, when the distribution processing unit 211 distributes the preparation data, based on the residual drug management information, the distribution processing unit 211 prepares preparation data that can use the remaining medicine already stored in the mixed injection working unit. It is conceivable to distribute to the mixed injection work section.

  For example, the distribution processing unit 211 generates a plurality of preparation data to be subjected to mixed injection work on the current day or the next day based on the remaining chemicals generated in the preceding mixed injection work (i.e. Cabinet 1 ”,“ Safety cabinet 2 ”, and“ Chemoro ”).

  Specifically, the distribution processing unit 211 prepares the preparation data relating to the second mixed injection work using the same type of chemical as the remaining chemical generated in the preceding first mixed injection work with the same mixed injection as the first mixed injection work. Distribute to the working part with priority. For example, when the mixed injection operation using the medicine A is scheduled to be performed twice on the same day and the first mixed injection operation is scheduled to be performed in the “safety cabinet 2”, the distribution processing unit 211 is set to 2 The preparation data corresponding to the second mixed injection work is preferentially distributed to “safety cabinet 2”. As a result, the remaining chemicals generated in the first mixed injection work can be used in the second mixed injection work without taking the residual chemicals outside the mixed injection work unit, and the residual chemicals can be used effectively. It becomes possible.

  The distribution processing unit 211 may distribute each of the preparation data to the plurality of mixed injection working units based on a predetermined distribution condition in addition to the remaining medicine generated in the preceding mixed injection operation. .

  For example, the distribution processing unit 211 may distribute each of the prepared data to the plurality of mixed injection work units based on the execution time of the mixed injection operation corresponding to each of the preparation data as an example of the distribution condition. . For example, the distribution processing unit 211 distributes each of the prepared data to the plurality of mixed injection work units so that a plurality of mixed injection operations performed at the same time or near time do not concentrate on the same mixed injection operation unit. May be. Accordingly, it is possible to prevent the mixed injection work from being concentrated on a specific mixed injection working unit and delaying the mixed injection operation to be performed in the mixed injection working unit.

  In addition, as an example of the distribution condition, the distribution processing unit 211 may distribute each of the preparation data to the plurality of mixed injection working units based on the administration time of the medicine collected in the mixed injection operation. For example, the distribution processing unit 211 sets each of the preparation data to the plurality of preparation data so that the mixed injection operation of each of the preparation data scheduled to be administered at the same time or near time does not concentrate on the same mixed injection operation unit. You may distribute to a mixed injection operation part. Accordingly, it is possible to prevent the mixed injection work from being concentrated on a specific mixed injection working unit and delaying the mixed injection operation to be performed in the mixed injection working unit.

  The distribution processing unit 211 may distribute each of the preparation data to the plurality of mixed injection work units based on the work time required for the mixed injection operation as an example of the distribution condition. For example, the distribution processing unit 211 may distribute each of the preparation data to the plurality of mixed injection work units so that mixed injection work having a long work time does not concentrate on the same mixed injection work unit. . Accordingly, it is possible to prevent the mixed injection work from being concentrated on a specific mixed injection working unit and delaying the mixed injection operation to be performed in the mixed injection working unit.

  In addition, as an example of the distribution condition, the distribution processing unit 211 may distribute each of the preparation data to the plurality of mixed injection work units based on the number of times the drug is collected from the chemical container in the mixed injection operation. . For example, the distribution processing unit 211 is configured so that the mixed injection work in which the number of times the medicine is collected from the chemical container (that is, the mixed injection work requiring a long work time) is not concentrated on the same mixed injection work part. Each piece of data may be distributed to the plurality of mixed injection working units. Accordingly, it is possible to prevent the mixed injection work that requires a long operation time from being concentrated in a specific mixed injection work unit and delay the mixed injection operation to be performed in the mixed injection operation unit.

  In addition, the distribution processing unit 211 may distribute each of the preparation data to the plurality of mixed injection work units based on whether or not the remaining medicine is used in the mixed injection operation as an example of the distribution condition. For example, the distribution processing unit 211 may preferentially distribute the prepared data corresponding to the mixed injection operation using the remaining medicine generated in the preceding mixed injection operation to a specific mixed injection operation unit. Then, the distribution processing unit 211 may distribute the preparation data corresponding to the mixed injection operation that does not use the remaining medicine generated in the preceding mixed injection operation to an arbitrary mixed injection operation unit. Accordingly, the mixed injection operation using the remaining medicine generated in the preceding mixed injection operation is preferentially distributed to the automatic mixed injection device 5, or the specific safety cabinet 100 (for example, the safety cabinet assigned to a skilled pharmacist). 100).

  In addition, the distribution processing unit 211 may distribute each of the preparation data to the plurality of mixed injection working units based on the type of medicine collected in the mixed injection operation as an example of the distribution condition. For example, the distribution processing unit 211 may preferentially distribute the preparation data corresponding to the mixed injection operation using powdered medicine (that is, the mixed injection operation requiring a stirring operation) to the automatic mixed injection device 5. Thereby, it is possible to cause the automatic co-infusion apparatus 5 to perform a co-infusion operation that requires labor, such as an agitation operation, and to reduce the labor of a worker (pharmacist) required for the co-infusion operation. In addition, the distribution processing unit 211 may preferentially distribute the preparation data corresponding to the mixed injection work using chemicals having a high risk of exposure to the automatic mixed injection device 5. Thereby, the safety | security in mixed injection work can be improved.

  In addition, the distribution processing unit 211 may distribute each of the preparation data to the plurality of mixed injection working units based on the drug price of the medicine collected in the mixed injection operation as an example of the distribution condition. For example, the distribution processing unit 211 preferentially distributes the preparation data corresponding to the mixed injection operation using a drug with a high drug price to the same mixed injection operation unit as the preceding mixed injection operation in which the same type of residual drug is generated. Also good. And the said distribution process part 211 may distribute to the arbitrary mixed injection work part about the preparation data corresponding to the mixed injection work which uses the chemical | medical agent with a low drug price. As a result, chemicals with low drug prices and low need for effective use of residual chemicals can be distributed to any mixed injection work unit, so that mixed injection work is concentrated in a specific mixed injection work unit. It is possible to prevent the mixed injection work to be carried out in the process from being delayed. Further, the distribution processing unit 211 may preferentially distribute the preparation data corresponding to the mixed injection work using the medicine with a high drug price to the automatic mixed injection device 5. Thereby, since a medicine with a high drug price is collected with high accuracy without a mistake by the automatic co-infusion apparatus 5, it is possible to prevent the medicine with a high drug price from being wasted due to a mistake or the like.

  In addition, as an example of the distribution condition, the distribution processing unit 211 receives each of the preparation data based on the price of a closed drug transfer system (CSTD) used in the mixed injection operation. You may sort it into. The closed drug transfer system is configured such that when the medicine such as an anticancer agent having a high risk of exposure in the safety cabinet 100 is collected with a syringe, the medicine is used in the working chamber of the safety cabinet 100. 101 may be used to prevent leakage. On the other hand, since the co-infusion operation in the automatic co-infusion apparatus 5 is performed by a robot, the closed type drug transfer system is unnecessary. Therefore, the distribution processing unit 211 uses the closed drug transfer system for the preparation data corresponding to the mixed injection work using a medicine such as a part of anticancer agents having a high risk of exposure. The allocation destination may be determined by comparing the cost required when the mixed injection work is performed in the safety cabinet 100 with the cost required when the automatic mixed injection device 5 performs the mixed injection work.

  In addition, as an example of the distribution condition, the distribution processing unit 211 may distribute each of the preparation data to the plurality of mixed injection working units based on a usable period of the remaining medicine generated in the mixed injection operation. . The usable period is a period in which the remaining drug can be used (collected or administered) after the remaining drug is generated. The usable period may be set individually for each medicine. For example, in the mixed injection work performed at 9 o'clock, when the medicine whose usable period is set to 5 hours remains as a remaining medicine, the distribution processing unit 211 prepares data whose administration time is later than 14:00. May be determined as the preparation data corresponding to the mixed injection work without using the remaining medicine, and the distribution destination may be determined. In addition, for example, when a solution such as a physiological saline solution is injected into a drug container in which powder is stored and the powder is dissolved, and then collected with a syringe, the dissolved drug can be used quickly. Sometimes required. Therefore, for such powder medicine, the usable period may be set to be shorter than the liquid medicine.

  In addition, the distribution processing unit 211 sets each of the plurality of pieces of the preparation data so that the cost required for the mixed injection work corresponding to the plurality of pieces of preparation data (for example, the cost calculated based on the drug price) is minimized. May be distributed to the mixed injection work section. Thereby, the expense required for mixed injection work can be suppressed. In addition to the drug price, the cost may include the price of the closed drug transfer system used in the mixed injection operation. If there is a cost for each chemical container regardless of whether or not all the chemicals in the chemical container are used up, the drug price is multiplied by the unit price of the chemical container used (opened) in the mixed injection operation. Is calculated. In addition, when a cost is incurred according to the amount of medicine actually consumed (collected or discarded) among the medicines in the medicine container, the medicine price is actually consumed in the mixed injection work to the medicine price per unit quantity. Calculated by multiplying the amount of drug.

  In addition, the distribution processing unit 211 distributes each of the preparation data to the plurality of mixed injection work units so that the number of times the medicine is collected from the chemical container in the mixed injection operation corresponding to the plurality of preparation data is minimized. May be. For example, let us consider a case where a mixed injection operation using 0.9 bottles of the same kind of chemicals is performed in a situation where there are two chemical containers containing the remaining chemicals for 0.5 bottles. In this case, if the remaining chemical is used, two sampling operations are required, but if a new chemical container is used, only one sampling operation is required. In such a case, the distribution processing unit 211 may determine a distribution destination of the preparation data corresponding to the mixed injection operation on the assumption that the remaining medicine is not used in the mixed injection operation. Thereby, since the frequency | count of extraction of the chemical | medical agent from a chemical | medical agent container becomes the minimum, the fall of the working efficiency of the mixed injection operation | work by using a residual chemical | medical agent can be suppressed.

  The distribution processing unit 211 executes a grouping process (S131 in FIG. 9), a first distribution process (S132 in FIG. 9), and a second distribution process (S133 in FIG. 9). Also good. In the grouping process, one or a plurality of preparation data corresponding to the mixed injection operation in which the remaining medicine is generated and one or a plurality of preparation data corresponding to the mixed injection operation using the remaining medicine are grouped as one preparation data group. It becomes. In the first distribution process, the preparation data belonging to the preparation data group is distributed to the plurality of mixed injection working units in units of the preparation data group. In the second sorting process, after the first sorting process, the prepared data that does not belong to the prepared data group is distributed to the plurality of mixed injection working units.

  The distribution processing unit 211 may preferentially distribute the preparation data that matches the automatic work conditions indicating the conditions to be distributed to the automatic co-infusion apparatus 5 to the automatic co-infusion apparatus 5. For example, the distribution processing unit 211 may preferentially distribute the preparation data corresponding to the mixed injection work having a long work time to the automatic mixed injection device 5 as an example of the automatic operation condition. In addition, as an example of the automatic work condition, the distribution processing unit 211 may preferentially distribute the preparation data corresponding to the mixed injection work with a large number of times of collecting medicine from the chemical container to the automatic mixed injection device 5. . In addition, as an example of the automatic work condition, the distribution processing unit 211 preferentially distributes the preparation data corresponding to the mixed injection work using the remaining medicine generated in the preceding mixed injection work to the automatic mixed injection device 5. Also good. In addition, as an example of the automatic operation condition, the distribution processing unit 211 preferentially supplies preparation data corresponding to a mixed injection operation using powdered medicine (that is, a mixed injection operation requiring a stirring operation) to the automatic mixed injection device 5. You may distribute. In addition, the distribution processing unit 211 may preferentially distribute the preparation data corresponding to the mixed injection operation using a medicine with a high drug price to the automatic mixed injection device 5 as an example of the automatic operation condition. In addition, as an example of the automatic work condition, the distribution processing unit 211 sends preparation data corresponding to a mixed injection work using some chemicals such as anticancer agents having a high risk of exposure to the automatic mixed injection device 5. You may preferentially sort out.

  In addition, the distribution processing unit 211 may preferentially distribute the preparation data that matches the manual operation conditions indicating the conditions to be distributed to the safety cabinet 100 to the safety cabinet 100. For example, the distribution processing unit 211 may preferentially distribute the preparation data corresponding to the mixed injection work having a short work time to the safety cabinet 100 as an example of the manual work condition. In addition, as an example of the manual operation condition, the distribution processing unit 211 may preferentially distribute the preparation data corresponding to the mixed injection operation in which the number of times of drug extraction from the drug container is small to the safety cabinet 100. In addition, as an example of the manual work condition, the distribution processing unit 211 may preferentially distribute the preparation data corresponding to the mixed injection work that does not use the remaining medicine generated in the preceding mixed injection work to the safety cabinet 100. Good. In addition, as an example of the manual operation condition, the distribution processing unit 211 preferentially supplies preparation data corresponding to a mixed injection operation that does not use powdered medicine (that is, a mixed injection operation that does not require a stirring operation) to the safety cabinet 100. You may distribute. In addition, the distribution processing unit 211 may preferentially distribute the preparation data corresponding to the co-infusion operation using a medicine with a low drug price to the safety cabinet 100 as an example of the manual operation condition. In addition, as an example of the manual work condition, the distribution processing unit 211 may preferentially distribute the preparation data corresponding to the mixed injection work using chemicals with a low risk of exposure to the safety cabinet 100.

  The presentation processing unit 212 presents information regarding the distribution result by the distribution processing unit 211. For example, as shown in the distribution screen P1 shown in FIG. 11, the presentation processing unit 212 displays a list of the prepared data distributed to the mixed injection work unit for each of the three mixed injection operation units. The presentation processing unit 212 may be capable of printing out the same content displayed on the sorting screen P1 using a printing device connected to the communication network N1.

  In addition, the presentation processing unit 212 includes, for the preparation data distributed by the distribution processing unit 211, preparation data corresponding to a mixed injection operation in which a residual drug is generated and preparation data corresponding to a mixed injection operation in which no residual drug is generated. May be presented so as to be distinguishable from each other. Thereby, for example, when the user changes the distribution destination of the preparation data distributed by the distribution processing unit 211 to another mixed injection working unit, the preparation data corresponding to the mixed injection operation in which no remaining medicine is generated (that is, Even if the distribution destination is changed to another mixed injection working part, it is possible to easily determine the preparation data that does not affect the amount of remaining chemicals remaining finally.

  In addition, the presentation processing unit 212 includes, for the preparation data distributed by the distribution processing unit 211, preparation data corresponding to the mixed injection operation using the remaining medicine generated in the preceding mixed injection operation, and the preceding mixed injection operation. The preparation data corresponding to the mixed injection work that does not use the generated remaining medicine may be presented so as to be distinguishable from each other. Thereby, the worker (pharmacist) who performs the mixed injection work can easily confirm whether or not the remaining medicine should be used.

  In addition, the presentation processing unit 212 determines the total amount of medicine required when the remaining medicine is used according to the distribution result by the distribution processing unit 211 and the total amount of medicine required when the remaining medicine is not used. You may show the difference with the amount of money.

  In addition, the presentation processing unit 212 presents an amount corresponding to the remaining medicine that is finally wasted when the mixed injection operation corresponding to the plurality of preparation data is performed according to the distribution result by the distribution processing unit 211. May be.

  The remaining amount calculation processing unit 213 generates a residual drug generated in the mixed injection operation corresponding to the preparation data based on the dose of the medicine indicated in the preparation data and the predetermined amount of the medicine container in which the medicine is stored. The remaining amount is calculated. For example, if the dose of the medicine indicated in the preparation data is 90 mg and the predetermined amount of the medicine container in which the medicine is stored is 100 mg, the remaining amount of the remaining medicine calculated by the remaining amount calculation processing unit 213 is calculated. The amount will be 10 mg. Further, for example, when the drug dose indicated in the preparation data is 3800 mg and the predetermined amount of the drug container in which the drug is stored is 1000 mg, the remaining drug calculated by the remaining amount calculation processing unit 213 The remaining amount is 200 mg.

  Based on the calculation result of the remaining amount calculation processing unit 213, the remaining amount management processing unit 214 manages the type and remaining amount of the remaining drug remaining in one or a plurality of drug containers in each of the mixed injection working units. . The remaining amount management processing unit 214 receives the remaining medicine management information described later from each of the mixed injection support devices 4, and based on the remaining medicine management information, the type of remaining medicine and the remaining medicine in the entire mixed injection management system 1. It is possible to manage the amount.

  The presentation processing unit 212 can present the remaining amount of each medicine at the present time based on the information on the type and remaining amount of the remaining medicine managed by the remaining amount management processing unit 214 (FIG. 13).

  Hereinafter, an example of the procedure of the mixed injection management process executed by the control unit 21 of the mixed injection management apparatus 2 will be described with reference to FIGS. 8 and 9. Here, steps S11, S12, S13... Shown in FIG. 8 and FIG.

  In addition, it is also conceivable as another embodiment that the mixed injection management apparatus 2 includes a plurality of control units, and the mixed injection management process is executed by the plurality of control units. Furthermore, a part or all of the processing executed by the control unit 21 may be executed by an electronic circuit such as ASIC or DSP. Further, part or all of the processing executed by the control unit 21 may be performed by a control unit of another device (for example, the control unit 41 of the co-infusion support device 4, the first control unit 52 of the automatic co-infusion device 5, the automatic co-infusion device). 5 second control unit 53).

[Mixed injection management processing]
<Step S11>
First, in step S <b> 11 shown in FIG. 8, the control unit 21 displays a distribution screen P <b> 1 as shown in FIG. 10 according to a user operation on the operation unit 25 of the mixed injection management device 2. To display. The control unit 21 may display the distribution screen P1 on the display unit 34 of the client terminal 3 in response to a user operation on the operation unit 35 of the client terminal 3.

  As shown in FIG. 10, the distribution screen P1 includes a prescription selection area A11, a condition setting area A12, a plurality of mixed injection work area A13, a medicine amount display area A14, and a CSTD amount display area A15. included.

  The prescription selection area A11 is an area for selecting preparation data (prescription) to be distributed in a distribution process (S13) described later. The condition setting area A12 is an area for setting a distribution condition in the distribution process. The mixed injection work part area A13 is an area provided for each mixed injection work part as a distribution destination in the distribution process. In the medicine amount display area A14, the difference between the total amount of medicine required when the remaining medicine is used in accordance with the sorting result in the sorting process and the total price of medicine required when the remaining medicine is not used. This is the area to be displayed. The CSTD amount display area A15 is an area for displaying the number and amount of the closed drug transfer system (CSTD) required when the co-infusion operation is performed according to the distribution result in the distribution process.

  The user can select the preparation data to be the target of the sorting process by performing an operation on the prescription selection area A11 through the operation unit 25. For example, when it is desired to execute the sorting process for the preparation data corresponding to the mixed injection work of the medicine administered to the inpatient and outpatient on the next day, the user selects the check box corresponding to the inpatient and the check box corresponding to the outpatient. With both of the items checked, select the date of the next day. As a result, the corresponding preparation data is displayed in a list in the prescription selection area A11. Specifically, a preparation data image D11 corresponding to the corresponding preparation data is displayed in the prescription selection area A11. That is, the control unit 21 extracts one or a plurality of the preparation data from the plurality of preparation data stored in the storage unit 22 in accordance with a user operation on the prescription selection area A11. And the said control part 21 displays the said preparation data image D11 corresponding to the extracted preparation data on the said prescription selection area | region A11.

  In the preparation data image D11, for example, a serial number, information indicating a corresponding patient and regimen, a drug name of a drug used, and a dose of the drug are displayed. In addition, when a plurality of types of drugs (for example, a plurality of types of anticancer agents) are collected in the mixed injection operation corresponding to one preparation data, each drug of the plurality of types of drugs is displayed in the preparation data image D11. The name may be displayed.

  When any of the prepared data images D11 displayed in the prescription selection area A11 is operated (for example, clicked) by the user, the control unit 21 changes the display mode of the operated prepared data image D11. Let For example, the control unit 21 changes the background color of the preparation data image D11 from white indicating the non-selected state to green indicating the selected state. The display mode changing method by the control unit 21 described here is merely an example. Instead of changing the background color, the control unit 21 may change, for example, the character color, change the thickness of the character or line, or blink the character or image in a different pattern. Alternatively, the characters may be displayed in reverse video, or specific characters, symbols, images, or the like may be added. The same applies to the following description.

  The distribution screen P1 includes an all selection key K12 and an all release key K13. When the all selection key K12 is operated, the control unit 21 changes all the prepared data images D11 displayed in the prescription selection area A11 to the selected state. Moreover, the said control part 21 will change all the said preparation data images D11 currently displayed on the said prescription selection area | region A11 to a non-selection state, if the all cancellation | release key K13 is operated.

  The user can set a distribution condition in the distribution process by performing an operation on the condition setting area A12 through the operation unit 25. In the example shown in FIG. 10, three setting items of “safety cabinet”, “chemo”, and “use remaining medicine” are displayed in the condition setting area A12.

  The items “safety cabinet” and “chemolo” are items for setting a distribution destination in the distribution process. For example, as shown in FIG. 10, when “safety cabinet” is set to “2” and “chemo” is set to “present”, the sorting screen P1 includes two safety cabinets 100. And three said co-infusion work part area | regions A13 corresponding to one said automatic co-infusion apparatus 5 are displayed.

  The item “use remaining medicine” is an item for setting whether or not to use the remaining medicine generated in the preceding mixed injection work in the mixed injection work corresponding to the preparation data to be distributed in the distribution process. For example, if the remaining medicine is used during a busy morning time, more time is required for the co-injection work, which may be insufficient. Therefore, in the mixed injection work performed in the morning, the remaining chemicals generated in the preceding mixed injection work are left without being used, and in the mixed injection work performed in the afternoon, the remaining chemicals generated in the preceding mixed injection work (in the morning It is conceivable to use residual chemicals generated during mixed injection work). In this case, first, with the “use of remaining medicine” set to “none”, the distribution process is executed with the preparation data corresponding to the mixed injection work performed in the morning as the distribution target. In the state where “medicine use” is set to “present”, the distribution process may be executed with the preparation data corresponding to the mixed injection work performed in the afternoon as the distribution target.

<Step S12>
In step S12, the control unit 21 determines whether or not a predetermined distribution start operation has been performed. For example, the control unit 21 determines that the distribution start operation has been performed when the distribution start key K11 included in the distribution screen P1 is operated. And if the said control part 21 judges that the said distribution start operation was performed (S12: Yes), it will transfer a process to step S13, and if it judges that the said distribution start operation is not performed (S12: No) ), The process proceeds to step S15.

<Step S13>
In step S13, the control unit 21 sets the preparation data selected in the prescription selection area A11 (that is, the preparation data corresponding to the selected preparation data image D11) in the condition setting area A12. Based on the assigned distribution condition, the distribution process is executed. Hereinafter, an example of the distribution process will be described with reference to FIG. Here, a case will be described in which “use of remaining medicine” is set to “present” in the distribution condition.

<Step S131>
In step S131 shown in FIG. 9, the control unit 21 performs a grouping process. Specifically, the control unit 21 includes one or a plurality of preparation data corresponding to a mixed injection operation in which residual medicine is generated and one or a plurality of preparation data corresponding to the mixed injection operation using the residual medicine among the preparation data to be distributed. The preparation data is grouped as one preparation data group.

  In the grouping process, the control unit 21 first calculates, for each preparation data to be distributed, the remaining amount of remaining medicine that is generated when the remaining medicine is not used in the mixed injection operation corresponding to the preparation data. Specifically, the control unit 21 calculates the remaining amount based on the dose of the medicine indicated in the preparation data and the predetermined amount of the medicine container used in the mixed injection operation. For example, when the dose of the drug indicated in the preparation data is 140 mg and the predetermined amount of the drug container in which the drug is stored is 100 mg, all the drugs are collected from the first drug container (total amount is collected). 40 mg of medicine is collected (fractional collection) from the second medicine container. Therefore, the remaining amount of the remaining medicine calculated by the remaining amount calculation processing unit 213 is 60 mg. When the dose of the drug indicated in the preparation data is an integral multiple of the predetermined amount of the drug container used in the mixed injection operation, the entire amount is collected (that is, all the predetermined amount of drug is collected from the drug container). No fraction is collected (that is, only the medicine less than the predetermined amount is collected from the medicine container), and no residual medicine is generated in the mixed injection work corresponding to the preparation data.

  Then, the control unit 21 determines whether or not there is a preceding mixed injection operation in which the same kind of residual drug is generated (that is, a mixed injection operation having an earlier execution time) for each of the preparation data corresponding to the mixed injection operation in which the residual drug is generated. Determine whether. In this way, the control unit 21 correlates the preparation data corresponding to the mixed injection work in which the residual medicine is generated and the preparation data corresponding to the mixed injection work in which the residual chemical can be used, A plurality of preparation data finally associated with each other are grouped as one preparation data group.

  Hereinafter, as an example, a processing method in a case where a grouping process is performed on the following preparation data will be specifically described. In the mixed injection operation corresponding to the following preparation data, the same kind of chemicals shall be used. Moreover, in the mixed injection work corresponding to the following preparation data, the chemical container whose said predetermined amount is 100 mg shall be used. Moreover, the following preparation data shall be arranged in order with the early implementation time of mixed injection work.

(Preparation data A) Dose 140 mg
(Preparation data B) Dose 200 mg
(Preparation data C) Dose 160 mg
(Preparation data D) Dose 210 mg
(Preparation data E) Dose 150 mg
(Preparation data F) Dose 100 mg
(Preparation data G) Dose 130 mg

  First, the control unit 21 calculates the remaining amount of the remaining medicine generated in the mixed injection operation corresponding to each of the preparation data when the remaining medicine is not used. The calculation result is as follows.

(Preparation data A) Remaining amount 60 mg (number of chemical containers used: 2)
(Preparation data B) Remaining amount 0 mg (Number of chemical containers used: 2)
(Preparation data C) Residual amount 40 mg (Number of chemical containers used: 2)
(Preparation data D) Remaining amount 90 mg (Number of chemical containers used: 3)
(Preparation data E) Residual amount 50 mg (Number of chemical containers used: 2)
(Preparation data F) Remaining amount 0 mg (Number of chemical containers used: 1)
(Preparation data G) Remaining amount 70 mg (Number of chemical containers used: 2)

  Next, the control unit 21 performs preceding mixed injection in which the same kind of residual medicine is generated for each of the preparation data (here, preparation data A, C, D, E, and G) corresponding to the mixed injection work in which the residual medicine is generated. It is determined whether or not there is a work (that is, a mixed injection work with an earlier execution time). As a result, in the mixed injection work corresponding to the preparation data C, it can be seen that there is a possibility that the residual medicine generated in the mixed injection work corresponding to the preparation data A can be used. Further, it can be seen that in the mixed injection work corresponding to the preparation data D, there is a possibility that the remaining chemicals generated in the mixed injection work corresponding to the preparation data A and C can be used. Further, it can be seen that in the mixed injection work corresponding to the preparation data E, there is a possibility that the residual chemicals generated in the mixed injection work corresponding to the preparation data A, C, D may be used. Further, it can be seen that in the mixed injection work corresponding to the preparation data G, there is a possibility that the remaining chemicals generated in the mixed injection work corresponding to the preparation data A, C, D, E can be used.

  Here, paying attention to the preparation data C, in the mixed injection work (dose 160 mg) corresponding to the preparation data C, the remaining medicine (remaining amount 60 mg) generated in the mixed injection work corresponding to the preparation data A can be used. Therefore, the control unit 21 associates the preparation data A and the preparation data C with each other. When residual chemicals are used, no residual chemicals are generated in the mixed injection work corresponding to the preparation data C. That is, when the mixed injection operation corresponding to the preparation data C is completed, the remaining amount of the remaining medicine is 0 mg. Therefore, the control unit 21 groups the dispensing data A and the dispensing data C as one preparation data group. The total number of chemical containers required for the mixed injection operation corresponding to the preparation data group is three, which is one less than the total number of chemical containers used (4) when the remaining chemicals are not used.

  Next, paying attention to the preparation data D, the remaining amount of the remaining medicine is 0 mg at the time when the co-infusion operation corresponding to the preparation data D is started. Therefore, the remaining medicine cannot be used in the mixed injection work corresponding to the preparation data D. When the mixed injection operation corresponding to the preparation data D is completed, the remaining amount of the remaining medicine is 90 mg.

  Next, paying attention to the preparation data E, the remaining amount of the remaining medicine is 90 mg at the time when the co-infusion operation corresponding to the preparation data E is started. Therefore, in the mixed injection work corresponding to the preparation data E, the remaining medicine (90 mg) generated in the mixed injection work corresponding to the preparation data D can be used. Therefore, the control unit 21 associates the preparation data D and the preparation data E with each other. When the mixed injection operation corresponding to the preparation data E is completed, the remaining amount of the remaining medicine is 40 mg.

  Next, paying attention to the preparation data G, at the time when the co-infusion operation corresponding to the preparation data G is started, the remaining amount of the remaining medicine is 40 mg. Therefore, in the mixed injection work corresponding to the preparation data G, the remaining drug (40 mg) generated in the mixed injection work corresponding to the preparation data E can be used. Therefore, the control unit 21 associates the preparation data E and the preparation data G with each other. When the mixed injection operation corresponding to the preparation data G is completed, the remaining amount of the remaining medicine is 10 mg. The remaining medicine is not used in the subsequent mixed injection operation. Therefore, the control unit 21 groups the preparation data D, the preparation data E, and the preparation data G that are associated with each other as one preparation data group. The total number of chemical containers required for the mixed injection work corresponding to the preparation data group is five, which is two less than the total number of chemical containers that are not used (7).

  In this way, two preparation data groups are generated from the preparation data A to G described above.

<Step S132>
In step S132, the control unit 21 performs a first distribution process. Specifically, the control unit 21 distributes the preparation data belonging to the preparation data group to the plurality of mixed injection working units in the preparation data group unit. For example, the distribution destination of the preparation data belonging to the preparation data group may be determined so that the same number of preparation data as possible is distributed to the plurality of mixed injection working units, or determined based on the distribution condition. Also good. For example, when the preparation data corresponding to the mixed injection operation using the remaining medicine is preferentially distributed to a specific mixed injection operation unit as the distribution condition, the control unit 21 prepares belonging to each of the preparation data groups. Data is preferentially distributed to the specific mixed injection work unit.

<Step S133>
In step S133, the control unit 21 performs a second distribution process. Specifically, the control unit 21 distributes the preparation data not belonging to the preparation data group to the plurality of mixed injection working units. The allocation destination of the preparation data that does not belong to the preparation data group may be determined, for example, so that the same number of preparation data as possible is distributed to the plurality of mixed injection working units, or determined based on the distribution conditions. May be.

  In this way, the preparation data selected in the prescription selection area A11 (that is, the preparation data corresponding to the preparation data image D11 in the selected state) is based on the distribution condition set in the condition setting area A12. And distributed to a plurality of mixed injection working units. When the sorting process ends, the control unit 21 shifts the process to step S14 in FIG.

<Step S14>
In step S14, the control unit 21 causes the display unit 24 to display a distribution result obtained by the distribution process executed in step S13. Specifically, as shown in FIG. 11, the control unit 21 prepares data distributed to the mixed injection work unit in the corresponding mixed injection work unit area A13 for each distribution target mixed injection work unit in the distribution process. A preparation data image D12 corresponding to the above is displayed. In the example shown in FIG. 11, of the 38 preparation data selected in the prescription selection area A11, 16 preparation data are distributed to the “safety cabinet 1”, and another 16 preparation data are stored. The “safety cabinet 2” is allocated, and the remaining six preparation data are allocated to “chemolo”.

  In the preparation data image D12, for example, the administration time of the corresponding medicine, information indicating the corresponding patient and regimen, the medicine name of the medicine to be used, and the dosage of the medicine are displayed. In each of the mixed injection work area A13, for example, the preparation data image D12 is displayed so as to be arranged in order according to the administration time.

  In addition, the said control part 21 is the preparation data image D12 corresponding to the mixed injection operation | work using the residual chemical | medical agent which generate | occur | produces in the preceding mixed injection operation | movement among the preparation data images D12 currently displayed on the said mixed injection operation | work area | region A13. For example, the background color is displayed in yellow. Thereby, the worker (pharmacist) who performs the mixed injection work can easily grasp in which mixed injection work the remaining medicine should be used. In addition, the control unit 21 displays the background color of the preparation data image D12 corresponding to the mixed injection work that does not use the remaining chemical generated in the preceding mixed injection work and generates the residual chemical, for example, white. Further, the control unit 21 displays the preparation color image D12 corresponding to the mixed injection work that does not use the remaining chemical generated in the preceding mixed injection work and does not generate the residual chemical, for example, in gray.

  In addition, as an example of the information related to the distribution result by the distribution process, the control unit 21 includes a total amount of medicine required when the remaining medicine is used in the medicine amount display area A14 according to the distribution result in the distribution process. The difference from the total amount of medicine required when the remaining medicine is not used is displayed. Moreover, the said control part 21 displays the said difference calculated for every said mixed injection work part on the lower part of each said mixed injection work part area | region A13.

  In addition, as an example of information related to the distribution result by the distribution process, the control unit 21 is a closed drug transfer required when a co-infusion operation is performed in the CSTD amount display area A15 according to the distribution result in the distribution process. Displays the number and amount of the system (CSTD). In addition, the control unit 21 displays the number and amount of the closed drug transfer system (CSTD) calculated for each of the mixed injection work units at the lower part of each of the mixed injection operation unit areas A13.

<Step S15>
In step S15, the control unit 21 determines whether or not a predetermined display switching operation has been performed. For example, the control unit 21 determines that the display switching operation has been performed when the display switching key K14 included in the sorting screen P1 is operated. And if the said control part 21 judges that the said display switching operation was performed (S15: Yes), it will transfer a process to step S16, and if it judges that the said display switching operation is not performed (S15: No), The process proceeds to step S17.

<Step S16>
In step S16, the control unit 21 updates the amount information displayed in the medicine amount display area A14. Specifically, as an example of information related to the distribution result by the distribution process, the control unit 21 is finally wasted when a mixed injection operation is performed in the medicine amount display area A14 according to the distribution result in the distribution process. The amount corresponding to the remaining drug (hereinafter referred to as the remaining drug amount) is displayed. When the display switching key K14 is operated again in a state where the remaining medicine amount is displayed in the medicine amount display area A14, the control unit 21 displays the difference in the medicine amount display area A14. Display again.

<Step S17>
In step S17, the control unit 21 determines whether or not a predetermined prepared operation has been performed. For example, the control unit 21 performs the prepared operation when the prepared key K16 included in the sorting screen P1 is operated in a state where one or a plurality of the prepared data images D12 are selected. Judge that For example, the prepared operation is performed whenever the mixed injection operation corresponding to the prepared data image D12 is completed. And if the said control part 21 judges that the said prepared operation was performed (S17: Yes), it will transfer a process to step S18, and if it judges that the said display switching operation is not performed (S17: No), The process proceeds to step S19.

<Step S18>
In step S18, the control unit 21 updates the remaining medicine information. The remaining medicine information is information on the remaining medicine remaining in the plurality of mixed injection working sections, and is stored in the storage section 22, for example. The remaining medicine information includes, for example, various types of information such as the type of remaining medicine, the remaining amount, the date and time of opening, and the location (mixed injection work unit). The control unit 21 corresponds, for example, to the preparation data image D12, the remaining amount of the remaining medicine generated in the mixed injection work corresponding to the preparation data image D12 selected when the prepared operation is performed. Calculation is based on the preparation data and the current remaining drug information. And the said control part 21 updates the said remaining medicine information based on the said calculation result.

  The control unit 21 changes the outline of the prepared data image D12 that was selected when the prepared operation was performed, for example, to a red thick line. Thereby, the user can easily discriminate between the prepared data image D12 for which the mixed injection work has been completed and the prepared data image D12 for which the mixed injection work has not been completed. In the example of FIG. 12, a state is shown in which all the mixed injection work corresponding to the preparation data whose administration time is earlier than 12:00 is completed.

  Further, it is conceivable that the control unit 21 prints the remaining medicine authentication label to be attached to a medicine container or the like in which the remaining medicine is generated. Thereby, the operator can easily grasp the contents of the remaining medicine in the medicine container by attaching the remaining medicine authentication label to the medicine container or the placement place of the medicine container. The printing of the remaining medicine authentication label is not limited to the step S18, and may be executed at a preset timing or may be executed at an arbitrary timing according to a print request operation performed by the operator.

<Step S19>
In step S19, the control unit 21 determines whether or not a predetermined remaining medicine confirmation operation has been performed. For example, the control unit 21 determines that the remaining medicine confirmation operation has been performed when the remaining medicine confirmation key K15 included in the sorting screen P1 is operated. And if the said control part 21 judges that the said remaining medicine confirmation operation was performed (S19: Yes), it will transfer a process to step S20, and if it judges that the said remaining medicine confirmation operation is not performed (S19: No) ), The process proceeds to step S21.

<Step S20>
In step S20, the control unit 21 causes the display unit 24 to display a remaining medicine screen P2 as shown in FIG. 13 based on the remaining medicine information. The remaining medicine screen P2 includes an entire display area A21 and a plurality of mixed injection work area A22.

  The overall display area A21 is an area for displaying the total remaining amount obtained by totaling the remaining medicines remaining in each of the mixed injection working sections for each kind of medicine. In the entire display area A21, for example, information such as a medicine name (for example, “One Taxotere”, “Vitaza”, etc.), mg value, mL value, and number of medicines is displayed for each kind of medicine. The mg value and the mL value indicate the total remaining amount of the medicine. The number indicates the total number of drug containers in which the drug remains. For example, when 20 mg of medicine A remains in a medicine container with a predetermined amount of 100 mg and 110 mg of medicine A remains in a medicine container with a predetermined amount of 200 mg, the mg value for medicine A is 130, The number is two.

  The mixed injection work part area A22 is an area for displaying information on the remaining medicine remaining in the corresponding mixed injection work part. The mixed injection work area A22 includes an upper area A221 and a lower area A222.

  The upper area A221 of the mixed injection work section area A22 is an area for displaying information on the remaining medicine remaining in the corresponding mixed injection work section for each same type of chemical container. In the upper area A221, for example, for each same type of chemical container, information such as a chemical container name (for example, “One Taxotere 20 mg”, “Vitaza 100 mg”, etc.), mg value, mL value, and number is displayed. . The mg value and the mL value indicate the total remaining amount of medicines in one or a plurality of the same kind of medicine containers in the corresponding mixed injection working unit. The number indicates the number of one or a plurality of the same kind of chemical containers in which the chemical remains.

  When one or a plurality of medicines among the medicines displayed in the entire display area A21 are selected by the user, the control unit 21 relates to the medicine selected by the user as shown in FIG. Only the information is displayed in the mixed injection work area A22. Thereby, the user can easily grasp, for example, how many drug containers in which a desired drug remains in which mixed injection work unit.

  When one or a plurality of medicine containers among the medicine containers displayed in the upper area A221 are selected by the user, the control unit 21 may select the medicine selected by the user as shown in FIG. Detailed information about the container is displayed in the lower area A222. In the lower area A222, for example, information such as a serial number, a remaining amount image, a mg value, a mL value, and a start date / time is displayed for each medicine container. The remaining amount image is an image schematically showing the remaining amount of remaining medicine in the medicine container. The mg value and the mL value are numerical values indicating the remaining amount of the remaining medicine in the medicine container. The start date and time is the date and time when the co-infusion operation using the chemical container was first performed.

  Although omitted in the flowchart shown in FIG. 8, when the close key K21 included in the remaining medicine screen P2 is operated, the control unit 21 closes the remaining medicine screen P2, and the distribution screen P1. Is displayed again on the display unit 24.

<Step S21>
In step S21, the control unit 21 determines whether or not a predetermined end operation has been performed. For example, the control unit 21 determines that the end operation has been performed when the close key K18 included in the sorting screen P1 is operated. And if the said control part 21 judges that the said completion operation was performed (S21: Yes), it will terminate the said mixed injection management process, and if it judges that the said completion operation is not performed (S21: No), a process will be performed. The process returns to step S12.

  Although omitted in the flowchart shown in FIG. 8, for example, when the clear key K17 included in the sorting screen P1 is operated in the state shown in FIG. 11 or FIG. The distribution screen P1 is returned to the state shown in FIG.

  Although omitted in the flowchart shown in FIG. 8, when the statistical key K19 included in the distribution screen P1 is operated, the control unit 21 causes the display unit 24 to display a statistical screen (not shown). The statistical screen displays statistical information related to mixed injection work performed in a specific period (for example, the past month, the past year, or a month designated by the user).

  The statistical screen shows, for example, the number of chemical containers actually used in the mixed injection operation performed during the specific period for each same type of chemical container, and the chemical containers required when no residual chemicals are used. The difference from the number may be displayed. In addition, the statistical screen shows the drug price for the number of drug containers actually used based on the difference between the drug containers and the number of drug containers required when no residual drug is used. The difference from the drug price may be displayed. Thereby, the monetary effect by having used the residual chemical | medical agent in the said specific period can be confirmed easily. Moreover, the said difference may be displayed on the said statistics screen P3 for every doctor who ordered the said mixed injection operation | work. Thereby, the said monetary effect for every doctor can be confirmed easily.

  As described above, in the mixed injection management system 1 according to the present embodiment, the preparation data corresponding to the mixed injection work in which the remaining medicine is generated and the preparation data corresponding to the mixed injection work using the remaining medicine are the same mixed injection work. It is distributed to the department. Therefore, the remaining medicine generated in one mixed injection work can be used in another mixed injection work without taking out the chemical container in which the chemical remains in the outside of the mixed injection work section. Therefore, according to the mixed injection management system 1 according to the present embodiment, it is possible to support the efficient use of the medicine stored in the medicine container.

  Note that the present invention is not limited to anticancer agents, and is a drug that should be co-injected in an aseptic state, and is particularly effective in sorting prepared data corresponding to co-infusion using expensive drugs.

[Modification]
In another embodiment, the control unit 21 may transmit each of the preparation data to the mixed injection support device 4 or the automatic mixed injection device 5 based on the distribution result by the distribution processing unit 211. For example, the control unit 21 transmits the prepared data distributed to the “safety cabinet 1” to the mixed injection support device 4 corresponding to the “safety cabinet 1”, and the prepared data distributed to the “safety cabinet 2”. It may be transmitted to the mixed injection support device 4 corresponding to the “safety cabinet 2”, and the prepared data distributed to “chemo” may be transmitted to the automatic mixed injection device 5. The mixed injection support device 4 may execute the mixed injection support process based on the preparation data received from the mixed injection management device 2. In the automatic co-infusion apparatus 5, the automatic co-infusion process may be executed based on the preparation data received from the co-infusion management apparatus 2.

  Further, in this embodiment, when it is determined in step S17 in FIG. 8 that the prepared operation has been performed, the remaining medicine information is updated in step S18. In other embodiments, the mixed injection support is performed. When the work completion notification signal indicating that the mixed injection work is completed is received from the device 4 or the automatic mixed injection device 5, the remaining medicine information may be updated. The work completion notification signal includes, for example, preparation data identification information for identifying preparation data corresponding to a completed mixed injection work.

  In another embodiment, the distribution screen P1 or the remaining medicine screen P2 may be displayed on the operation display unit 42 of the co-infusion support apparatus 4 or the display 541 of the automatic co-infusion apparatus 5. A user operation on the sorting screen P1 or the remaining medicine screen P2 may be performed through the operation display unit 42 of the co-infusion support apparatus 4 or the operation unit 525 of the automatic co-infusion apparatus 5.

  Further, in the present embodiment, as described above, the remaining amount calculation processing unit 213 performs the preparation based on the dose of the medicine indicated in the preparation data and the predetermined amount of the medicine container in which the medicine is stored. Calculate the remaining amount of the remaining chemicals generated in the mixed injection work corresponding to the data. However, depending on the type of the chemical container, a larger amount of chemical than the predetermined amount may be always stored. For example, 105 mg of medicine may be always stored in a medicine container having the predetermined amount of 100 mg. Therefore, when using such a chemical container, the mixed injection management system 1 is provided with a function of correcting the predetermined amount so that the chemical contained in the chemical container can be used without waste. May be. For example, a correction coefficient (for example, “1.05” or the like) for correcting the predetermined amount may be stored in the storage unit 22 or the like for each type of chemical container. The correction coefficient may be set or changed according to a user operation. The remaining amount calculation processing unit 213 corrects the predetermined amount of the medicine container in which the medicine is stored by multiplying the correction coefficient, and corrects the medicine dose indicated in the preparation data and the corrected default. Based on the amount, the remaining amount of the remaining medicine generated in the mixed injection operation corresponding to the preparation data may be calculated. In addition, when the co-infusion operation is performed by the robot in the automatic co-infusion apparatus 5, a more accurate amount of medicine can be collected from the chemical container than in the case where the co-infusion operation is performed by a person in the safety cabinet 100. . Therefore, the remaining amount calculation processing unit 213 calculates the remaining amount of the remaining medicine generated in the mixed injection work performed in the automatic co-infusion apparatus 5 and the remaining medicine generated in the mixed injection operation performed in the safety cabinet 100. The correction coefficient may be changed depending on when the remaining amount is calculated. For example, the remaining amount calculation processing unit 213 may make the correction coefficient smaller in the latter case than in the former case.

  Particularly, in the mixed injection work performed in the safety cabinet 100, since the mixed injection work is performed by a person, an amount of medicine larger than the amount to be collected may be collected. As a result, the actual remaining amount becomes smaller than the remaining amount calculated by the remaining amount calculation processing unit 213. Therefore, in order to cope with such a situation, the mixed injection management system 1 may be provided with a function of correcting the remaining amount calculated by the remaining amount calculation processing unit 213. For example, the control unit 21 may correct the remaining amount calculated by the remaining amount calculation processing unit 213 by multiplying a predetermined correction coefficient less than 1. The correction coefficient may be set or changed according to a user operation.

  In another embodiment, the control unit 21 may present information related to whether or not the remaining medicine generated in each of the mixed injection operations should be discarded based on the distribution result in the distribution process. . For example, the control unit 21 determines whether or not the remaining medicine generated in each of the mixed injection operations is likely to be used in the subsequent mixed injection operation. For example, the control unit 21 determines that the remaining medicine is not expected to be used in the subsequent mixed injection operation when there is no subsequent mixed injection operation that uses the same kind of medicine as the remaining medicine. May be. And the said control part 21 specifies the display mode of the preparation data image D12 which is not expected to be used in the mixed injection operation | work which the said remaining chemical | medical agent follows among the preparation data images D12 corresponding to the mixed injection operation | movement which a residual chemical | medical agent generate | occur | produces. (For example, addition of characters, symbols or images indicating that the remaining medicine should be discarded) may be changed. Thereby, the worker (pharmacist) of the mixed injection work can immediately discard the remaining medicine that is not expected to be used in the subsequent mixed injection work. Therefore, it is possible to prevent unnecessary residual chemicals from being stored in the safety cabinet 100 and causing the chemical containers to be mixed.

  In another embodiment, the control unit 21 changes the preparation data images D12 displayed in the mixed injection work area A13 on the distribution screen P1 for each preparation data group to which the corresponding preparation data belongs. You may display in a display mode. For example, the control unit 21 may add a number, a symbol, or an image for identifying the preparation data group to which each preparation data image D12 belongs to each preparation data image D12.

  In another embodiment, the preparation data automatically distributed in the distribution process may be configured to be redistributed and changed to another mixed injection working unit according to a user operation. For example, in response to a drag-and-drop operation on the preparation data image D12 displayed in the mixed injection work area A13 on the distribution screen P1, the control unit 21 determines the distribution destination of the preparation data corresponding to the preparation data image D12. It may be changed. In addition, when the preparation data corresponding to the preparation data image D12 belongs to any one of the preparation data groups, a plurality of preparation data belonging to the preparation data group are assigned to the drag-and-drop operation. Depending on the situation, the same mixed injection work unit may be changed collectively.

  Moreover, in other embodiment, the said remaining medicine information may be comprised so that a user can change arbitrarily as needed. For example, the control unit 21 may update information such as the remaining amount and location of the remaining medicine included in the remaining medicine information in response to a user operation on the remaining medicine screen P2. As a result, for example, when chemicals are spilled during mixed injection work, when the mixed injection work is performed in a mixed injection work unit different from the mixed injection work part distributed in the distribution process, the user can make the remaining as necessary. Drug information can be updated to correct information.

  In another embodiment, the mixed injection work unit of the distribution destination in the distribution process may be a safety cabinet in which the mixed injection support device 4 is not provided.

  Further, in another embodiment, the mixed injection work unit as the distribution destination in the distribution process may be only the mixed injection work unit (ie, the safety cabinet 100) where the mixed injection work is performed by a person.

  In another embodiment, the mixed-dose operation unit that is the distribution destination in the distribution process may be only the mixed-dose operation unit in which the mixed injection operation is performed by the robot (that is, the automatic mixed injection device 5).

  Further, in the present embodiment, the case where there are a plurality of distribution destination mixed injection work units in the distribution process has been described, but it is also conceivable that the distribution destination has a single mixed injection operation unit. In this case, in the distribution process, all the preparation data selected as the distribution target are assigned to one mixed injection working unit, and the total amount of chemicals required when the remaining chemicals are used is displayed in the chemical amount display area A14. The difference between the amount of money and the total amount of medicine required when the remaining medicine is not used will be displayed. The difference varies depending on the setting content of the setting item “use remaining medicine” in the condition setting area A12. For example, in a mixed injection operation performed in the morning, the remaining chemicals generated in the preceding mixed injection operation are left without being used, and in a mixed injection operation performed in the afternoon, the remaining chemicals generated in the preceding mixed injection operation (in the morning It is conceivable to use residual chemicals generated during mixed injection work). In this case, first, with the “remaining drug use” set to “none”, the first distribution process is executed with the preparation data corresponding to the mixed injection work performed in the morning as the distribution target, The second distribution process may be executed with the preparation data corresponding to the mixed injection work performed in the afternoon as the distribution target in a state where “use of remaining medicine” is set to “present”. In this case, if mixed injection work using the same kind of chemicals is concentrated in the morning, the remaining chemicals generated in the morning cannot be used up in the mixed injection work performed in the afternoon. The part is wasted. Therefore, the user limits the preparation data for setting “use of remaining medicine” to “none” to, for example, preparation data to be administered in the time zone from 9 o'clock to 10 o'clock, and re-executes the distribution process, The amount displayed in the medicine amount display area A14 may be confirmed. If the remaining drug generated in the mixed injection operation corresponding to the preparation data administered in the time zone from 9:00 to 10:00 is used in the mixed injection operation corresponding to the preparation data administered in the time zone from 11:00 to 12:00. In this case, the remaining medicine that is finally wasted decreases, and the amount displayed in the medicine amount display area A14 changes. As described above, according to the mixed injection management system 1 according to the present embodiment, even when there is one mixed injection work unit as a distribution destination in the distribution process, efficient use of the chemical stored in the chemical container is supported. Is possible.

[Other embodiments]
By the way, as described above, after the mixed injection operation based on the preparation data input to the mixed injection support device 4 is performed, when the chemical remains in the chemical container used in the mixed injection operation, the chemical container is Until the next use, the work chamber 101 may be stored. Hereinafter, the case where the mixed injection support device 4 includes a medicine storage unit 300 on which a plurality of medicine containers can be placed will be described. In addition, the same code | symbol is used about the same component as the component demonstrated by the said embodiment about the said mixed injection assistance apparatus 4. FIG. In the mixed injection management system 1 including the mixed injection support device 4 according to the present embodiment, the mixed injection management device 2 does not have to execute the mixed injection management process (see FIG. 8).

  As shown in FIG. 16, the medicine storage unit 300 is communicably connected to the control unit 41 of the co-infusion support apparatus 4. For example, the medicine storage unit 300 is connected to the mixed injection support device 4 so as to be capable of short-range wireless communication, or connected to the mixed injection support device 4 with a communication cable. The mixed injection support device 4 may include a plurality of the medicine storage units 300, and each of the medicine storage units 300 may be connected to the mixed injection support device 4 so as to be communicable. In this case, in the mixed injection support device 4, each medicine storage unit 300 can be identified by a unit number set in advance for each medicine storage unit 300. The power supply to the medicine storage unit 300 is performed from the mixed injection support device 4 or a commercial AC power supply.

  As shown in FIG. 17, the medicine storage unit 300 is disposed in the safety cabinet 100 at a position accessible to an operator who performs the mixed injection work in the safety cabinet 100. FIG. 17 shows a state where a plurality of medicine containers 400 are placed on the medicine storage unit 300. The medicine storage unit 300 has a circular shape in plan view, and the medicine storage unit 300 has, for example, an outer diameter of 300 mm and a height of 190 mm.

  As shown in FIGS. 18 and 19, the medicine storage unit 300 includes an upper stage mounting part 310, a lower stage mounting part 320, and a rotation support part 330. Each of the upper stage placing part 310 and the lower stage placing part 320 includes a plurality of medicine placing parts 301 on which medicine containers can be placed. As shown in FIG. 19, the medicine placement part 301 is arranged in a ring shape in each of the upper stage placement part 310 and the lower stage placement part 320. The medicine placement portion 301 is formed with a recess where the medicine container is placed, and the recess is inclined outward from below to above. That is, the medicine placement part 301 has a shape that allows the medicine container to be inclined outward when the medicine container is placed. Thereby, the loading and unloading of the medicine container with respect to the medicine placing portion 301 is prepared. In addition, the bottom surface of the concave portion of the drug placement portion 301 is, for example, a plane parallel to a horizontal plane or a plane perpendicular to the inclination of the concave portion.

  The rotation support part 330 supports the upper stage mounting part 310 and the lower stage mounting part 320 so as to rotate together. Specifically, in the present embodiment, the upper stage placement unit 310 and the lower stage placement unit 320 in the medicine storage unit 300 are rotatable within a preset range of 360 degrees or less. Thus, the operator can access the arbitrary medicine placement unit 301 by rotating the upper stage placement unit 310 and the lower stage placement unit 320. In addition, each of the said upper stage mounting part 310 and the said lower stage mounting part 320 may be supported so that rotation is possible separately. In addition, the rotation support unit 330 may include a driving unit such as a stepping motor or a DC motor that rotates the upper stage mounting unit 310 and the lower stage mounting unit 320. In this case, the control unit 41 can rotate the upper stage mounting unit 310 and the lower stage mounting unit 320 by controlling the driving unit of the rotation support unit 330 according to a user operation. In addition, if the rotation position of the upper stage placement unit 310 and the lower stage placement unit 320 of the medicine storage unit 300 can be detected, the control unit 41 places the medicine container in the medicine placement unit 301. When placing or taking out, it is possible to rotate the upper stage placing part 310 and the lower stage placing part 320 to the position where the medicine placing part 301 is close to the operator. In addition, the chemical | medical agent storage unit 300 is not provided with the said rotation support part 330, and the structure which the said chemical | medical agent storage unit 300 is not circular by planar view is also considered. For example, the medicine storage unit 300 may include a plurality of the medicine placement units 301 arranged in parallel along a linear shape, an arc shape, an L shape, or the like.

  Each of the drug placement units 301 is provided with a placement detection unit 311 and a status display unit 312. In addition, a shelf number for identifying the medicine placement section 301 is set in each medicine placement section 301, and the control section 41 can identify each medicine placement section 301.

  Each of the placement detection units 311 is an optical sensor or a mechanical sensor used to detect whether or not the medicine container is placed on the medicine placement unit 301 corresponding to the placement detection unit 311. is there. The detection result by each of the placement detectors 311 is input to the control unit 41 of the mixed injection support device 4.

  Each status display unit 312 is used to indicate the state of the medicine placement unit 301 corresponding to the status display unit 312. The contents displayed by each status display unit 312 are controlled by the control unit 41 of the co-infusion support apparatus 4. Specifically, each of the status display units 312 includes a light emitting element (LED) capable of emitting a plurality of colors, and indicates the state of the medicine placement unit 301 according to the light emission color and the light emission mode of the light emitting element. In the present embodiment, the case where the status display unit 312 includes an LED capable of emitting two colors of red and blue will be described as an example.

  Further, the status display unit 312 is disposed inside the upper stage mounting unit 310 and the lower stage mounting unit 320, and the surface 310A of the upper stage mounting unit 310 and the surface 320A of the lower stage mounting unit 320 are , Transparent, translucent, or made of a highly transparent material. Accordingly, the light of the status display unit 312 can be visually recognized from the outside through the surface 310A of the upper stage mounting unit 310 or the surface 320A of the lower stage mounting unit 320. Further, the status display unit 312 may be provided to be exposed on the surface 310A of the upper stage mounting unit 310 and the surface 320A of the lower stage mounting unit 320. Further, the status display unit 312 may be an annular light emitting unit provided along the outer peripheral edge of the drug placement unit 301.

  Specifically, the storage unit 413 stores correspondence information indicating a correspondence relationship between the emission color and emission mode of the status display unit 312 and the state of the medicine placement unit 301, and the control unit 41 The status display unit 312 is controlled based on the correspondence information. For example, the control unit 41 turns off the status display unit 312 when the medicine container is not placed on the medicine placement unit 301. In addition, the control unit 41 turns on the status display unit 312 in blue when the effective medicine container whose expiration date has not yet arrived is placed on the medicine placement unit 301, so that the medicine placement is performed. When the invalid chemical container whose expiration date has arrived is placed in the unit 301, the status display unit 312 is lit in red. The expiration date is, for example, a time limit for using the medicine in the medicine container, and is a timing after elapse of a preset period (for example, 6 hours) after opening the medicine container. In addition, when the medicine placement unit 301 is the current placement destination of the medicine container, or when the medicine placement unit 301 is the current take-out target of the medicine container, The status display unit 312 blinks in blue. Further, the control unit 41 causes the status display unit 312 to blink in red when there is an error in placing the medicine container on the medicine placing unit 301 or an error in taking out the medicine container.

  In the co-infusion support apparatus 4, the control unit 41 executes a remaining medicine storage process and a remaining medicine use process for supporting management of the medicine container using the medicine storage unit 300. FIG. 20 is a flowchart showing an example of the remaining medicine storage process, and FIG. 23 is a flowchart showing an example of the remaining medicine use process. Note that either or both of the remaining medicine storage process and the remaining medicine use process are executed by the control unit 21 of the mixed injection management apparatus 2, and the mixed injection support apparatus 4 receives information from the mixed injection management apparatus 2. Based on this, it may be used as an operation display terminal that accepts user operations or displays various screens.

[Residual medicine storage processing]
First, an example of the remaining medicine storage process will be described with reference to FIG.

<Step S31>
In step S31, the control unit 41 determines whether or not the co-infusion work performed by the worker is completed based on the preparation data. Specifically, the control unit 41 determines that the mixed injection work has been completed when an operation for ending the mixed injection operation is performed on the foot switch unit 45. Here, if it is determined that the mixed injection work has been completed (S31: Yes), the process proceeds to step S32, and if it is determined that the mixed injection work has not been completed (S31: No), the process is stepped. The process proceeds to S35.

<Step S32>
In step S <b> 32, the control unit 41 determines whether or not residual medicine is generated in the medicine container used in the mixed injection operation. For example, the control unit 41 determines whether or not residual chemicals are generated based on the preparation data. In addition, when the medicine container stored in the medicine storage unit 300 is used in the mixed injection operation, the control unit 41 determines the remaining medicine based on the remaining medicine management information and the preparation data described later. Determine whether it occurred. Furthermore, the control unit 41 may determine that the remaining medicine has been generated when an operation input indicating that the remaining medicine has been generated by a user operation. Here, when it is determined that the remaining medicine is generated (S32: Yes), the process proceeds to step S33, and when it is determined that the remaining drug is not generated (S32: No), the process proceeds to step S35. . Further, when the control unit 41 determines that the remaining medicine is generated, the control unit 41 prints the remaining medicine authentication label including the contents of the remaining medicine by the printer 44. The determination as to whether or not residual medicine is generated in the medicine container used in the mixed injection operation and the printing of the residual medicine authentication label may be performed before the completion of the mixed injection operation. In step S32, the control unit 41 counts the number of times the needle is pierced by the syringe with respect to the chemical container performed in the mixed injection operation even when the residual chemical is generated in the chemical container used in the mixed injection operation. When the number of times has reached a preset number of times (for example, two times) or more, it may be determined that there is no remaining chemical in the chemical container. Therefore, in the mixed injection support process, the control unit 41 executes a count process for counting the number of times the needle is stabbed by the syringe, for example, when performing guidance display of a suction process for sucking a drug from the drug container.

<Step S33>
In step S33, the control unit 41 determines the medicine placement unit 301 on which the medicine container is not placed among the medicine placement units 301 based on the remaining medicine management information stored in the storage unit 413. It is specified as the placement destination of the chemical container this time. In addition, when a residual medicine arises about the said several chemical | medical agent container, the mounting place is specified about each of the said chemical | medical agent container.

  FIG. 21 is a diagram showing an example of the remaining medicine management information according to the present embodiment. As shown in FIG. 21, the remaining medicine management information includes information such as a storage location number, medicine identification information, storage date and time, and a remaining liquid amount of the medicine storage unit 300 as a placement destination. The remaining medicine management information is updated in step S38 or step S47 described later. In addition, the said control part 41 when performing the process for memorize | storing the said remaining medicine management information in the memory | storage part 413 is an example of the memory | storage process part in this invention. The medicine identification information is a medicine code that can identify the type of the remaining medicine. The storage date and time is information indicating the date and time when the drug container is stored as a remaining drug, but for example, the start date and time or end date and time of mixed injection work based on the preparation data is used instead. The amount of residual liquid is information indicating the amount of residual chemical determined to be generated in step S32. The control unit 41 may be capable of printing out a form indicating the content of the remaining medicine management information using a printing device or the like connected on the communication network N1.

  The storage location number is a combination of a unit number that is identification information of the medicine storage unit 300 and a shelf number that is identification information of the medicine placement unit 301 in the medicine storage unit 300. Specifically, as shown in FIG. 19, the medicine storage unit 300 according to the present embodiment is provided with six medicine placement parts 301 in the upper stage placement part 310, and the lower stage placement. The twelve medicine placement units 301 are provided in the placement unit 320. In this embodiment, as shown in FIG. 22A and the like, shelf numbers “1” to “12” are set in each of the drug placement units 301 of the lower stage placement unit 320, and the upper stage It is assumed that shelf numbers “21” to “26” are set in each of the medicine placement units 301 of the placement unit 310.

  In addition, it is possible that the said control part 41 specifies the mounting place of the said chemical | medical agent container based on the preset conditions in the said step S33. For example, the control unit 41 is arranged so that the arrangement of the chemical containers stored in the chemical storage unit 300 is not biased as much as possible, or the arrangement of the chemical containers stored in the chemical storage unit 300 is concentrated as much as possible. In addition, it is conceivable to specify the placement destination of the chemical container this time. Moreover, you may specify the said control part 41 as a mounting place of the said chemical | drug | medicine container in order from the said chemical | medical agent mounting part 301 with a small shelf number, or the said chemical | drug | medicine mounting part 301 with a large shelf number. Further, the control unit 41 may specify the placement destination of the chemical container according to a selection operation by an operator from the chemical placement unit 301 on which the chemical container is not placed.

<Step S34>
In step S <b> 34, the control unit 41 executes a process for notifying the medicine placement unit 301 that is the placement destination of the current medicine container. Specifically, the control unit 41 drives the status display unit 312 of the medicine placement unit 301 specified as the placement destination in step S33 with blue blinking indicating that the placement is the current placement destination. .

  Furthermore, the control unit 41 moves each status display unit 312 from the reference position P20 set in advance in the medicine storage unit 300 toward the medicine placement unit 301 specified as the placement destination of the medicine container. It is conceivable to repeat the sequential lighting process of sequentially lighting red. Thereby, the operator can grasp | ascertain easily the said chemical | drug | medicine mounting part 301 of the mounting place of the said chemical | drug | medicine container.

  22A to 22D are diagrams illustrating an example of the sequential lighting process. First, as shown in FIG. 22A, consider a case where the shelf number of the medicine placement unit 301 specified as the placement destination of the medicine container is “1”. In this case, the status display unit 312 of the medicine placement unit 301 with the shelf number “1” blinks in blue. Further, the status display section 312 of the medicine placement section 301 with the shelf numbers “12” to “2” is sequentially lit in red toward the medicine placement section 301 with the shelf number “1” from the reference position P20. The lighting process is sequentially repeated to guide the position of the medicine placement unit 301 as a placement destination.

  Further, as shown in FIG. 22B, consider a case where the shelf number of the medicine placement unit 301 specified as the placement destination of the medicine container is “12”. In this case, the status display unit 312 of the medicine placement unit 301 with the shelf number “12” blinks in blue. Further, the status display units 312 of the medicine placement units 301 with the shelf numbers “1” to “11” are sequentially turned on from the reference position P20 toward the medicine placement unit 301 with the shelf number “12”. The lighting process is repeated, and the position of the medicine placement unit 301 at the placement destination is guided.

  Further, as shown in FIG. 22C, consider a case where the shelf number of the medicine placement unit 301 specified as the placement destination of the medicine container is “4”. In this case, the status display unit 312 of the medicine placement unit 301 with the shelf number “4” blinks in blue. Further, the status display section 312 of the medicine placement section 301 with the shelf numbers “1” to “3” sequentially lights in red toward the medicine placement section 301 with the shelf number “4” from the reference position P20. The sequential lighting process is repeated, and the sequential lighting process of sequentially lighting the status display units 312 of the medicine placement units 301 of the shelf numbers “12” to “5” is repeated. That is, the position of the medicine placement part 301 as a placement destination is guided by branching left and right from the reference position P20.

  Further, as shown in FIG. 22D, a case is considered where the shelf number of the medicine placement unit 301 specified as the placement destination of the medicine container is “8”. In this case, the status display unit 312 of the medicine placement unit 301 of the shelf number “8” blinks in blue. Further, the status display section 312 of the medicine placement section 301 with the shelf numbers “1” to “7” is sequentially lit in red toward the medicine placement section 301 with the shelf number “8” from the reference position P20. The sequential lighting process is repeated, and the sequential lighting process of sequentially lighting the status display units 312 of the medicine placement units 301 of the shelf numbers “12” to “9” is repeated. That is, the position of the medicine placement part 301 as a placement destination is guided by branching left and right from the reference position P20.

  In addition, it is conceivable that the medicine storage unit 300 is provided with a position detection unit that can detect the rotational positions of the upper stage placement part 310 and the lower stage placement part 320 of the medicine storage unit 300. In this case, the control unit 41 sets the position closest to the operator as the reference position P20 from the reference position P20 toward the drug placement unit 301 of the placement destination, and the status of the other drug placement units 301 It is conceivable that the display unit 312 is sequentially lit in red. In addition, when the control unit 41 specifies the drug placement unit 301 as the placement destination in the step S33, the medicine in which the drug container is not placed based on the detection result by the position detection unit. It is also conceivable to specify the medicine placement part 301 present at the position closest to the operator among the placement parts 301 as the placement destination of the current medicine container. 22A to 22D, the control unit 41 may cause the operation display unit 42 to display an image indicating the reference position P20 and the position of the medicine placement unit 301 as a placement destination. Good. Thereby, for example, if the reference position P20 is written in the medicine storage unit 300, the operator can easily grasp the position of the medicine placement unit 301 as a placement destination.

<Step S35>
In step S <b> 35, the control unit 41 determines whether or not the chemical container is placed on the chemical placement unit 301. Specifically, the control unit 41 determines whether or not the medicine container is placed based on the detection result by the placement detection unit 311 of each of the medicine placement units 301. Here, if it is determined that the medicine container is placed on the medicine placing section 301 (S34: Yes), the process proceeds to step S35, and the medicine container is placed on the medicine placing section 301. If it is not determined (S35: No), the process returns to step S31. In addition, until it is judged that the said chemical | drug | medicine container was mounted in the said chemical | drug | medicine mounting part 301 (S35: No), it is also considered as another embodiment that a process waits in said step S35.

<Step S36>
In step S36, the control unit 41 determines whether or not the placement destination of the chemical container is correct. Specifically, when the medicine placement unit 301 of the current placement destination is specified in the step S33, the control unit 41 places the medicine container on the medicine placement unit 301. In this case, it is determined that the placement destination of the chemical container is correct. Further, in the step S33, the medicine placement unit 301 of the current placement destination is not specified, and the medicine registered that the medicine container is not placed in the medicine management information. When the medicine container is placed on the placement unit 301, it is determined that the placement destination of the medicine container is not correct. Here, when it is determined that the placement destination of the medicine container is correct (S36: Yes), the process proceeds to step S37, and when it is judged that the placement destination of the medicine container is not correct (S36). : No), the process proceeds to step S361.

<Step S361>
In step S361, the control unit 41 notifies the medicine container placement error, and returns the process to step S31. Specifically, the control unit 41 drives the status display unit 312 of the medicine placement unit 301 on which the medicine container is placed with blinking red corresponding to the placement error described above. Further, the control unit 41 causes the operation display unit 42 to display a message indicating a placement error of the chemical container. Thereby, the operator can grasp | ascertain easily the mounting mistake of the said chemical | drug | medicine container.

<Step S37>
In step S37, the control unit 41 executes a process for notifying the medicine placing unit 301 on which the medicine container is placed. Specifically, the control unit 41 drives the status display unit 312 of the medicine placement unit 301 on which the medicine container is placed with blue lighting corresponding to the placement state of the medicine container.

<Step S38>
In step S38, the control unit 41 updates the remaining medicine management information. Specifically, the control unit 41 records a storage location number, chemical identification information, storage date and time, and a residual liquid amount in the residual drug management information for the chemical container that is determined to have a residual chemical in Step S32. . When the medicine container is used in a plurality of the mixed injection operations, for example, the start date / time or the end date / time of the first mixed injection operation is recorded as the storage date / time.

  By the way, in said step S33-S36, the said chemical | drug | medicine mounting part 301 of the mounting destination of the said chemical | drug | medicine container is pinpointed by the said control part 41, and the appropriateness | suitability of mounting | wearing of the said chemical | medical agent container to the said chemical | medical agent mounting part 301 is determined. The case where it is determined has been described as an example. On the other hand, a configuration is also conceivable in which an operator can arbitrarily select a placement destination of the chemical container. Specifically, the control unit 41 detects the placement of the medicine container on the medicine placement unit 301 in place of the steps S33 to S36, and uses the detected medicine placement unit 301 as the medicine. It may be possible to identify the container as a placement destination. Thereby, the operator can place the medicine container at an arbitrary position without searching for the medicine placing unit 301 specified by the control unit 41. In addition, when the control unit 41 performs an operation for selecting the drug placement unit 301 on the foot switch unit 45 of the operator in the step S33, the drug placement unit 301 is changed. It is also conceivable to specify the placement destination of the chemical container.

[Residual medicine use processing]
Next, the remaining medicine use process will be described with reference to FIG.

<Step S41>
In step S41, the control unit 41 determines, based on the remaining medicine management information, whether or not the remaining medicine can be used in the mixed injection work based on the preparation data selected as a processing target in the mixed injection support process. to decide. The said control part 41 when performing the process which concerns here is an example of the judgment process part in this invention. Here, if it is determined that the remaining medicine can be used in the mixed injection operation (S41: Yes), the process proceeds to step S42, and if it is determined that the residual medicine is not available in the mixed injection operation (S41). : No), the process proceeds to step S44.

<Step S42>
In step S42, the control unit 41 determines whether or not a remaining medicine that can be used in the mixed injection work based on the preparation data selected as a processing target in the mixed injection support process is selected. Specifically, the control unit 41 operates a list of remaining medicines that can be used in the mixed injection work based on the preparation data selected as a processing target in the mixed injection support process based on the residual drug management information. It is displayed on the display unit 42 and accepts an operation for selecting the remaining medicine by the operator. If it is determined that the remaining medicine to be used is selected (S42: Yes), the process proceeds to step S43. If it is determined that the remaining medicine to be used is not selected (S42: No), the process is performed. The process proceeds to step S44.

<Step S43>
In step S43, the control unit 41 executes a process for notifying the storage position where the chemical container used this time is stored. Specifically, the control unit 41 blinks in blue to indicate that the status display unit 312 of the drug placement unit 301 in which the drug container selected in Step S32 is accommodated is the current extraction target. Drive. Hereinafter, among the chemical containers stored in the chemical storage unit 300, the chemical container used this time may be referred to as a residual drug container.

  In addition, the control unit 41 sequentially moves the status display units 312 from the reference position P20 set in advance in the medicine storage unit 300 toward the medicine placement unit 301 that stores the medicine container to be taken out. It is conceivable to repeat the sequential lighting process of turning red. Thereby, the operator can grasp | ascertain easily the said chemical | drug | medicine mounting part 301 of the said chemical | medical agent container of taking-out object. In addition, in the mixed injection support process, the control unit 41 also displays that the remaining medicine container is used as the chemical container on the guidance screen that displays the contents (preparation procedure) of the mixed injection work. The control unit 41 may cause the operation display unit 42 to display an image indicating the reference position P20 and the position of the medicine placement unit 301 to be taken out.

<Step S44>
In step S <b> 44, the control unit 41 determines whether or not the medicine container has been removed from the medicine placement unit 301. Specifically, the control unit 41 determines whether or not the medicine container has been taken out based on a detection result by the placement detection unit 311 of each medicine placement unit 301. If it is determined that the medicine container has been removed (S44: Yes), the process proceeds to step S45. If it is not determined that the medicine container has been removed (S44: No), the process proceeds to step S48. . In addition, until it is judged that the said chemical | medical agent container was taken out (S44: No), it is also considered as another embodiment that a process waits at the said step S44.

<Step S45>
In step S45, the control unit 41 determines whether or not the taken medicine container is correct. Specifically, when the remaining medicine to be used in step S42 is selected, the control unit 41 detects the medicine placement unit 301 corresponding to the placement detection unit 311 that detects the removal of the medicine container. However, if the remaining medicine management information is registered as the placement destination of the remaining medicine container to be taken out, it is determined that the removed medicine container is correct. In addition, the control unit 41 reads the one-dimensional code or the two-dimensional code of the residual drug authentication label attached to the residual drug container to be taken out by the first reading unit 43 or the second reading unit 46. In such a case, it may be determined that the removed chemical container is correct. Furthermore, when the medicine container used as the remaining medicine is not selected in the step S423, the medicine placement unit 301 registered that the medicine container is placed in the medicine management information. When the medicine container is taken out from the container, it is determined that the taken medicine container is not correct. Here, when it is determined that the extracted medicine container is correct (S45: Yes), the process proceeds to step S46, and when it is determined that the extracted medicine container is not correct (S45: No), The process proceeds to step S451.

<Step S451>
In step S451, the control unit 41 notifies the medicine container take-out error, and shifts the process to step S48. Specifically, the control unit 41 drives the status display unit 312 of the medicine placement unit 301 from which the medicine container has been taken out by blinking red corresponding to the removal error. Further, the control unit 41 causes the operation display unit 42 to display a message indicating the medicine container removal error. Thereby, the operator can grasp | ascertain easily the erroneous taking-out of the said chemical | medical agent container.

<Step S46>
In step S46, the control unit 41 executes a process for notifying the medicine placing unit 301 from which the remaining medicine container has been taken out. Specifically, the control unit 41 turns off the status display unit 312 of the medicine placement unit 301 from which the remaining medicine container has been taken out.

<Step S47>
In step S47, the control unit 41 updates the remaining medicine management information. Specifically, the control unit 41 deletes the storage location number, the medicine identification information, the storage date and time, and the remaining liquid amount from the medicine management information for the medicine container selected to be used as the remaining medicine in Step S42.

<Step S48>
In step S <b> 48, the control unit 41 determines based on the remaining medicine management information whether or not a medicine container whose expiration date has arrived is stored in the medicine storage unit 300. Specifically, a usable period after opening of a medicine is set in advance for each kind of medicine in the medicine master or the like, and the control unit 41 uses the usable period and the remaining medicine management information in the medicine master. It is possible to determine whether the expiration date has arrived based on the storage date and time. Here, if it is determined that the medicine container whose expiration date has passed is stored (S48: Yes), the process proceeds to step S49, and the medicine container whose expiration date has passed is not stored. If it is determined (S48: No), the process is returned to step S41.

<Step S49>
In step S49, the control unit 41 notifies a request for taking out the chemical container whose expiration date has come. Specifically, the control unit 41 drives the status display unit 312 of the medicine placement unit 301 in which the medicine container whose expiration date has been received is accommodated with blinking red indicating that the medicine is to be taken out. Let Further, the control unit 41 displays a message on the operation display unit 42 urging the user to take out the medicine container that has expired.

  In addition, the management of the expiration date of the remaining medicine in the steps S48 to S49 may be executed only when the following conditions (A) to (C) are satisfied. (A) A remaining medicine authentication label including a one-dimensional code or a two-dimensional code indicating the contents of the remaining medicine is printed by the printer 44 at the start of the mixed injection operation. (B) In the said residual medicine storage process, taking out from the said chemical | drug | medicine mounting part 301 of the said chemical | medical agent container is monitored. (C) A one-dimensional code or a two-dimensional code is read by the first reading unit 43 when the chemical container is placed on the chemical placement unit 301. Further, when the removal of the medicine container in the step S42 is guided, the control unit 41 removes the medicine container when the first reading unit 43 reads the one-dimensional code or the two-dimensional code of the medicine container. It is also possible to leave a record after judging that the process has been completed successfully.

  Moreover, the said control part 41 may be able to receive extraction start operation of arbitrary chemical | medical containers among the said chemical containers according to arbitrary selection operation by an operator. In this case, the control unit 41 notifies the removal request of the medicine container arbitrarily selected by the operator, similarly to the step S49, and when the medicine container is taken out, it is taken out in the step S45. It can be considered that the chemical container is correct. Furthermore, it is also conceivable that the control unit 41 notifies all the medicine container removal requests when a work end operation is performed by an operator or when a preset work end time comes.

  As described above, in the mixed injection support device 4, the placement location of the medicine container in the medicine storage unit 300 is managed, and the medicine placement section 301 of the placement location of the medicine container as necessary. Alternatively, since the medicine placement unit 301 from which the medicine container is to be taken out is notified, the efficiency of placing and taking out the medicine container is improved.

  By the way, in the mixed injection management system 1, a plurality of the mixed injection support devices 4 may be connected, and the medicine storage unit 300 may be provided in one or a plurality of the mixed injection support devices 4. Therefore, it is conceivable that the storage location number information includes a device number that is identification information of the mixed injection support device 4. In addition, the remaining medicine management information can be referred to between the mixed injection support apparatuses 4, the remaining medicine management information is stored and shared in a specific mixed injection support apparatus 4, and the mixed injection support is performed. It is conceivable that the remaining medicine management information is synchronized between the devices 4. In this case, in the step S33, the control unit 41 sets not only the medicine storage unit 300 of the mixed injection support device 4 on which the control unit 41 is mounted but also the medicine storage unit 300 of another mixed injection support device 4. It is also conceivable that the medicine placement unit 301 can be specified as a placement destination. Further, when it is determined in step S41 whether or not the remaining medicine is available, the medicine storage of not only the mixed injection support device 4 on which the control unit 41 is mounted but also the other mixed injection support device 4 is stored. Residual chemicals in the chemical container stored in the unit 300 may be considered. Even when the remaining medicine to be used in step S42 is selected, it is stored not only in the mixed injection support device 4 on which the control unit 41 is mounted but also in the chemical storage unit 300 of the other mixed injection support device 4. The drug container may be selectable. When the medicine container stored in the medicine storage unit 300 of another mixed injection support device 4 is selected, the control unit 41 corresponds to the other mixed injection support device 4 in step S43. Based on the medicine management information, the location of the medicine container may be displayed on the operation display unit 42 or the like.

  Furthermore, it is conceivable that the remaining medicine information and the remaining medicine management information can be referred to each other between the mixed injection support apparatus 4 and the mixed injection management apparatus 2. In this case, the control unit 41 may be able to consider the remaining medicine stored in the automatic co-infusion apparatus 5 in steps S41 to S43. For example, in step S41, it is determined that the remaining medicine can be used when the remaining medicine that can be used in the mixed injection work based on the preparation data exists in the automatic co-infusion apparatus 5. In step S42, the automatic medicine is determined to be available. It is also conceivable that the remaining medicine stored in the co-infusion apparatus 5 can be selected. In this case, in the step S43, the operation display unit 42 or the like is displayed that the storage location of the remaining medicine to be used is the automatic co-infusion apparatus 5.

[Residual drug use / non-use selection function]
In the remaining medicine use process (see FIG. 23), when it is determined that the remaining medicine can be used in the mixed injection operation based on the preparation data, the remaining medicine that can be used is selected, and the remaining medicine is stored. The configuration (S41 to S43) in which the storage position is informed has been described. On the other hand, when the mixed injection support device 4 starts a mixed injection operation for the preparation data to be processed in the mixed injection support process, a residual drug use presence / absence selection that allows an operator to select whether or not to use a residual drug is selected. A configuration having a function is conceivable.

  Specifically, in the mixed injection support process, the control unit 41 causes the operation display unit 42 to sequentially display a guidance screen including information related to a work process necessary for the mixed injection work. For example, as described above, the work process includes a chemical authentication process, a tare drawing process, a dissolution liquid extraction process, a dissolution liquid measurement process, a dissolution liquid imaging process, a dissolution process, a chemical extraction process, a chemical measurement process, and a chemical imaging process. , And work processes necessary from the mixed injection process. In addition, the said chemical | medical agent certification | authentication process is a process performed at least before the said chemical | medical solution extraction process, In the said chemical | medical agent certification | authentication process, the chemical | drug | medicine which the chemical | medical agent code read by the 2nd reading part 46 from a chemical | medical agent container is performed from now on is performed. It is determined that there is no mistake in the medicine when it coincides with the medicine to be subjected to the chemical liquid extraction process.

  Here, the said control part 41 is performing the said remaining medicine utilization process with the said mixed injection assistance process, and in the said remaining medicine utilization process, the mixed injection based on the said preparation data selected as the process target of the said mixed injection assistance process When residual chemicals can be used in the work, it is conceivable that the operator can select whether or not the residual chemicals are used. FIG. 24 is a flowchart showing another example of the remaining drug use process, and the control unit 41 when executing the remaining drug use process is an example of the selection processing unit in the present invention.

  As shown in FIG. 24, when the control unit 41 determines in step S41 that the remaining medicine can be used in the mixed injection work based on the preparation data selected as the processing target of the mixed injection support process. (S41: Yes), the following step S411 is executed. In the remaining drug use process shown in FIG. 24, step S42 is omitted.

<Step S411>
In step S411, the control unit 41 causes the operation display unit 42 to display a guidance screen P11 for allowing an operator to select whether or not to use the remaining medicine. FIG. 25A is a diagram showing a display example of the guidance screen P11.

  As shown in FIG. 25A, the guidance screen P11 includes display areas A111 to A113. Specifically, the control unit 41 displays a message indicating that the remaining medicine is available in the display area A111. In addition, the control unit 41 displays a medicine name or a medicine code that can identify the medicine type of the remaining medicine in the display area A112. Further, the control unit 41 includes various operation keys including an operation key K111 for selecting that the remaining medicine is used and an operation key K112 for selecting that the remaining medicine is not used in the display area A113. Is displayed.

  By the way, in the mixed injection work, the amount of work (working efficiency) may be different depending on whether the remaining chemical is used or not. Specifically, when only a medicine container that contains less than the amount of the medicine corresponding to the dosage of medicine shown in the preparation data is stored in the medicine storage unit 300 in the safety cabinet 100, After using the remaining chemical in the chemical container, it is necessary to use the remaining chemical in another chemical container. For this reason, the operator needs to perform the work of sucking the medicine from the medicine container containing the remaining medicine with the syringe and the work of sucking the medicine from the other medicine container with the syringe. The working time is longer than when the medicine is sucked with a syringe.

  Therefore, the control unit 41 displays information such as a work amount (work efficiency) between when the remaining medicine is used and when not used, or a difference in the work amount, on the guide screen P11 of the operation display unit 42. It is possible. Thereby, the worker can determine whether or not to use the remaining medicine in consideration of the work amount (working efficiency).

  Specifically, it is conceivable that the control unit 41 determines the number of drug containers to be used when using or not using the remaining drug during storage based on the preparation data and the remaining drug management information. . Specifically, the control unit 41 stores a chemical container in which the amount of residual medicine corresponding to the dosage of medicine indicated by the preparation data is stored in the medicine storage unit 300 in the safety cabinet 100. It may be judged that the number of used chemical containers is the same and the amount of work (working efficiency) is the same when using residual chemicals during storage and when using new unused chemical containers. Conceivable. On the other hand, when the medicine container that stores the amount of the remaining medicine corresponding to the dosage of medicine indicated by the preparation data is not stored in the medicine storage unit 300 in the safety cabinet 100, the control unit 41 The medicine is collected from a plurality of medicine containers stored in the medicine storage unit 300 and used, or both the medicine container stored in the medicine storage unit 300 and a new unused medicine container are used. You will collect and use medicines. Therefore, in such a case, it may be determined that the number of used chemical containers is increased and the work amount (working efficiency) is deteriorated as compared with a case where only a new unused chemical container is used.

  Therefore, for example, the control unit 41, based on the preparation data and the remaining medicine management information, the syringe necessary for the mixed injection operation in each case of using the remaining medicine and not using the remaining medicine It may be possible to display information such as whether or not there is a change in the number of needle sticks depending on the number of times of needle sticks due to or the presence or absence of use of residual chemicals. The number of needle sticks can be counted based on various preparation procedures stored in advance in the storage unit 413. Specifically, when the mixed injection operation is performed using a single medicine container, the needle sticking work for removing the medicine from the medicine container and the needle sticking work for injecting the medicine into the infusion bag are performed twice. Needle piercing work is necessary. On the other hand, when the mixed injection operation is performed using two chemical containers, the needle puncturing operation for removing the chemical from the chemical container and the needle puncturing operation for injecting the chemical into the infusion bag are performed twice each. Since it is necessary to do this, a total of four needle stick operations are required. Note that the information displayed on the guidance screen P11 is information that can grasp the difference in work amount (working efficiency) between when the remaining medicine is used and when not used, for example, when the remaining medicine is used. It may be the number of medicine containers used in each case where the remaining medicine is not used.

<Step S412>
Next, in step S412, the control unit 41 determines whether or not the operator has selected to use the remaining medicine on the guidance screen P11. Specifically, in the present embodiment, the control unit 41 determines that the use of the remaining medicine is selected when the operation key K111 is operated, and the remaining medicine when the operation key K112 is operated. It is determined that not to use is selected.

  Here, if it is determined that the use of the remaining medicine is not selected (S412: No), the process proceeds to step S44. In addition, when it is selected that the remaining medicine is not used, the control unit 41 displays a message or the like for reconfirming that the remaining medicine is not used, and remains according to the operator's operation on the message. It may be possible to reselect whether or not to use chemicals.

  On the other hand, if it is determined that the use of the remaining medicine has been selected (S412: Yes), the process proceeds to step S43. And the said control part 41 performs the process for alert | reporting the accommodation position of the chemical | medical agent container in which the residual chemical | medical agent used as a utilization object is accommodated in the said step S43 (S43). Moreover, the said control part 41 may display the accommodation position of the said chemical | drug | medicine container in the said step S43, when the said guidance screen P11 is displayed in the said step S411.

  In step S43, the control unit 41 includes at least a chemical container containing a residual chemical that can be used in the mixed injection work based on the preparation data selected as a processing target in the mixed injection support process. An accommodation position in the medicine storage unit 300 is notified only for a medicine container in which a medicine amount necessary for the mixed injection work is housed. Here, in step S43, the control unit 41 is a chemical container in which residual chemicals that can be used in the mixed injection work based on the preparation data are stored, and a chemical amount necessary for the mixed injection work is stored. In the case where there are a plurality of medicine containers, it is conceivable to display the storage position of a medicine container that matches a preset selection condition from the plurality of medicine containers. For example, the selection condition is that the storage date and time stored in the residual drug management information is the oldest, or the residual liquid amount stored in the residual drug management information is closest to the chemical amount required for the mixed injection operation That is.

  Further, in step S43, the control unit 41 performs the above-described operation for all the chemical containers that contain the remaining chemicals that can be used in the mixed injection work based on the preparation data selected as the processing target in the mixed injection support process. Notifying the storage position in the medicine storage unit 300 is also conceivable as another embodiment. That is, it is conceivable that the storage positions in the medicine storage unit 300 of all medicine containers containing the same medicine are notified regardless of whether or not the amount of medicine necessary for the mixed injection work is contained.

  Furthermore, it is conceivable that the control unit 41 can set in advance the conditions of the chemical container for which the accommodation position is notified in the step S43 according to the user operation. For example, as described above, the control unit 41 includes a first notification mode for notifying only the medicine container in which the amount of medicine necessary for the mixed injection operation is stored, and the remaining chemicals available for the mixed injection operation. Selection of any one of the notification modes with the second notification mode for notifying the storage positions of all the stored medicine containers is received by a user operation, and the notification in step S43 is executed in the selected notification mode.

  In addition, the control unit 41 may be able to set the notification mode in the initial setting of the mixed injection support device 4, but the notification mode is set according to a user operation while the guide screen P11 is displayed. It may be switchable. Further, when there is a medicine container that contains the amount of medicine necessary for the mixed injection operation, the control unit 41 performs notification in the first notification mode, and the amount of chemical necessary for the mixed injection operation is determined. When there is no medicine container accommodated, it is also conceivable to perform notification in the second notification mode.

  By the way, in the remaining medicine use process (see FIG. 24), when it is determined that the remaining medicine can be used in the mixed injection operation based on the preparation data, and it is determined that the remaining medicine can be used, the operator Whether or not the remaining chemical is used is selected according to the operation. On the other hand, the storage position in the medicine storage unit 300 of the medicine container in which the residual medicine that can be used by the worker is stored is known, or the medicine storage unit 300 is provided in the mixed injection management system 1. It is possible that there is no. Therefore, in step S412, the control unit 41 uses the first reading unit 43 or the second reading unit 46 to generate a one-dimensional code or a two-dimensional code of the residual drug authentication label attached to the residual drug container. Even when read, it may be determined that the use of the remaining medicine has been selected. In this case, it is conceivable that the control unit 41 omits steps S43 to S46 and shifts the process to step S47 in the remaining medicine use process (see FIG. 24). That is, when the one-dimensional code or the two-dimensional code of the remaining medicine authentication label is read in the step S412, the control unit 41 performs a selection operation to use the remaining medicine and the medicine in the step S45. It can be determined that the container authentication is performed at the same time.

  In addition, when the preparation data to be the target of the mixed injection work is selected, the control unit 41, when starting the mixed injection support process, separates the chemical container etc. used in the mixed injection work separately from the chemical authentication process. It is conceivable to execute a stock confirmation process for confirming the stock status. The assortment confirmation process is executed at least before the start of the remaining medicine use process (see FIG. 24) after the preparation data is selected. Specifically, in the assortment confirmation process, the control unit 41 determines that the identification information of one or a plurality of chemical containers and infusion bags used in the mixed injection operation based on the preparation data is the first reading unit 43 or the first. It is conceivable that, when read by the two reading unit 46, it is determined that the arrangement state is normal. In this case, the control unit 41 uses the one-dimensional code or the two-dimensional code of the remaining medicine authentication label attached to the remaining medicine container as the identification information of the medicine container used in the mixed injection operation. When read by the reading unit 43 or the second reading unit 46, it may be determined that an operation for using the remaining medicine in the remaining medicine container has been performed in the mixed injection operation. In this case, it is conceivable that the control unit 41 omits the steps S41, S411, S412, and S43 to S46 in the remaining medicine use process (see FIG. 24), and shifts the process to step S47.

  By the way, in the mixed injection operation, in the mixed injection operation, the chemical liquid extraction step of extracting the chemical from each chemical container for each of a plurality of types of chemicals may be executed. That is, a plurality of the chemical solution extraction steps may be sequentially performed, and a residual chemical may be generated in a plurality of chemical containers. In this case, the control unit 41 may execute the steps S41, S411, S412, and S43 at the timing each time the chemical extraction process for each medicine starts in the remaining medicine use process (see FIG. 24). Conceivable. In addition, when the preparation data to be subjected to the mixed injection work is selected, the control unit 41 may collectively determine whether or not the remaining chemicals can be used for each chemical used in the mixed injection work. The operator's operation for selecting whether or not the remaining medicine is used for the medicine that is determined to be usable at the time may be collectively accepted.

[Remaining liquid volume manual registration function]
In step S38 of the remaining medicine storage process (see FIG. 20), a determination result as to whether or not a remaining medicine is generated based on the preparation data in step S32 or based on the preparation data and the remaining medicine management information. The case where the remaining medicine management information is updated based on the above has been described. That is, in the step S38, the remaining liquid amount registered in the remaining medicine management information may be automatically calculated by the control unit 41 based on the preparation data or the remaining medicine management information.

  On the other hand, it is conceivable that the mixed injection support device 4 has a residual liquid amount manual registration function capable of registering information such as the residual liquid amount registered in the residual medicine management information in accordance with a manual operation by an operator. Specifically, when it is determined in step S32 that residual chemicals are generated (S32: Yes), the control unit 41 obtains information such as the residual liquid amount of the residual chemicals before the execution of step S38. It is conceivable to execute a manual registration process that can be registered in accordance with an operation. In addition, the said control part 41 when performing the said manual registration process is an example of the registration process part in this invention. Specifically, in the manual registration process, the control unit 41 causes the operation display unit 42 to display a guidance screen P12 including information such as a message indicating that a remaining medicine has occurred. FIG. 25B is a diagram showing a display example on the guidance screen P12.

  As shown in FIG. 25B, the guidance screen P12 displays a display area A114 where a message indicating that a remaining medicine has been generated is displayed. In particular, in the display area A114, based on the remaining medicine management information, whether or not a medicine container containing the same medicine as the remaining medicine is contained in the medicine storage unit 300 as a remaining medicine is stored. Information such as the number of bottles remaining and the total amount of residual liquid contained is displayed. For example, the number displayed in the display area A114 is a number including the number of chemical containers in which the currently generated residual medicine is stored, and the remaining liquid amount displayed in the display area A114 is: This is the amount of residual liquid, including the amount of residual liquid remaining.

  In the guidance screen P12, an operation key K113 for selecting to store the generated remaining medicine in the display area A113, and an operation key for selecting to discard the generated remaining medicine without storing it. K114, an operation key K115 for confirming the content of the remaining medicine, an operation key K116 for starting input of information such as the remaining liquid amount of the generated remaining medicine, and the like are displayed.

  And if the said operation key K113 is operated, the said control part 41 will memorize | store the information of the residual medicine which generate | occur | produced in the said residual medicine management information in the said step S38 after that. When the operation key K114 is operated, the remaining medicine storage process is terminated, and the process returns to step S31. In addition, when the operation key K115 is operated, the control unit 41 causes the operation display unit 42 to display the remaining medicine management information about a medicine container containing the same medicine as the remaining medicine. Further, when the operation key K116 is operated, the control unit 41 causes the operation display unit 42 to display a registration screen P21 on which information such as the remaining liquid amount of the generated remaining medicine can be input. FIG. 26A and FIG. 26B are diagrams showing an example of the registration screen P21. Specifically, FIG. 26A is a diagram illustrating an example of the registration screen P21 when the medicine initially contained in the medicine container is a liquid, and the medicine initially contained in the medicine container is a powder medicine. It is a figure which shows an example of the said registration screen P21 in the case. As another embodiment, it may be possible to display a screen in which the guide screen P12 and the registration screen P21 are integrated.

  As shown in FIG. 26A, in the registration screen P21 when the medicine is liquid, the management number, medicine identification information, remaining amount, start date and time (storage start date and time), etc. included in the remaining medicine management information are displayed. Is displayed. The remaining medicine management information includes management number, medicine identification information, remaining amount, start date / time (storage start date / time), use date / time, identification number of mixed injection working unit, unit number of medicine storage unit 300, medicine storage unit 300. Chemical container storage location, control number branch number, processing classification (during storage, removal), chemical code, dissolution liquid code, dissolution amount, predetermined amount, concentration, number of needle sticks, prescription number, Rp number, order number, etc. Is stored in association with each medicine container. Other information such as a storage location number indicating the storage location of the chemical container may be displayed on the registration screen P21. The management number is an identification number automatically given by the control unit 41 to identify each medicine container in the remaining medicine management information. The medicine identification information is identification information such as a medicine name or a medicine code for identifying the medicine type of the remaining medicine. The remaining amount is information indicating the amount of the remaining medicine stored in the medicine container. The start date and time is time information such as a use start date and time when the medicine container is opened.

  In addition, as shown in FIG. 26B, in the registration screen P21 when the medicine is a powder medicine, in addition to the case where the medicine is a liquid, an item of dissolution amount is displayed. The dissolved amount is information indicating the amount of liquid after dissolving the drug, and is the amount of liquid in a solvent such as infusion.

  Further, the registration screen P21 includes an input field A121 for inputting the remaining amount of medicine and an operation key K123 for registering information displayed on the registration screen P21 as the remaining medicine management information. Has been. The control unit 41 can accept an operation for changing the value of the remaining liquid amount in accordance with the operation of the numerical value change keys K121 and K122 displayed in the vicinity of the input field A121. Further, the control unit 41 can accept an input of the remaining liquid amount by text input or voice input after the operator selects the input field A121. Thereafter, when the operation key K123 is operated, the control unit 41 registers the information displayed on the registration screen P21 as the remaining medicine management information. Further, when a cancel operation is performed on the registration screen P21, the control unit 41 cancels the change of the remaining liquid amount, closes the registration screen P21, and displays the guidance screen P12. The control unit 41 can accept only the change operation of the remaining liquid amount in the input field A121 on the registration screen P21. For other information, for example, gray-out display is performed. It is conceivable to prohibit the change operation. However, as another embodiment, the control unit 41 may be able to accept a change operation for other information other than the remaining liquid amount on the registration screen P21.

  Here, the control unit 41 displays the registration screen P21 in a state where the remaining liquid amount automatically calculated based on the preparation data, the remaining medicine management information, or the like is input to the input field A121. Thereby, when there is no change in the numerical value input into the input field A121, the numerical value input operation by the operator can be omitted.

  In particular, the amount of medicine stored in an unused medicine container used in the mixed injection operation may be larger than a predetermined amount defined as the amount of medicine stored in the medicine container. In this case, if the residual liquid amount is automatically calculated based on the preparation data and the predetermined amount, there is a difference between the residual liquid amount and the residual liquid amount actually remaining in the chemical container. In some cases, the chemical contained in the chemical container cannot be used up in the residual liquid utilization process. Therefore, it is conceivable that the control unit 41 calculates the residual liquid amount in consideration of the actual medicine storage amount for each medicine container.

  Specifically, the control unit 41 obtains the actual amount indicating the amount of liquid actually stored in each medicine container separately from the predetermined amount of medicine registered in the medicine master stored in the storage unit 41. It is conceivable that the capacity information can be set according to a user operation. FIG. 27 is a diagram showing an example of the pharmaceutical master setting screen P31. As shown in FIG. 27, in the setting screen P31, an input field A131 corresponding to the amount of water is displayed, and the control unit 41 uses the value input to the input field A131 by a user operation as the actual storage amount. Can be set as Specifically, when the registration key K131 displayed on the setting screen P31 is operated, the control unit 41 registers the information displayed on the setting screen P31 in the medicine master, or the setting. The said pharmaceutical master is updated based on the information currently displayed on the screen P31.

  And when the unused medicine container is used in the mixed injection operation and a residual medicine is generated, the control unit 41 sets the amount of the remaining liquid based on the preparation data, and is set in the medicine master. The amount obtained by subtracting the amount of chemical used in the mixed injection operation corresponding to the preparation data from the actual amount stored is calculated as the remaining liquid amount and displayed in the input field A121. As a result, the amount of the remaining liquid to be stored is calculated in consideration of the actual storage amount, so that the medicine in the medicine container stored as the remaining medicine can be used up as much as possible without waste. For example, with the residual liquid amount calculated based on the predetermined amount, even if it is determined that the mixed injection work cannot be performed even if the residual liquid amount is used, the actual liquid storage amount is used. In the residual liquid amount calculated in this way, it may be determined that the co-infusion operation can be performed using the chemical of the residual liquid amount. In addition, the said control part 41, when a residual chemical | medical agent generate | occur | produces in the said mixed injection operation | work using the chemical | medical agent container stored in the said chemical | medical agent storage unit 300, the said chemical | medical agent container registered into the said residual drug management information. The amount obtained by subtracting the amount of chemical used in the mixed injection operation corresponding to the preparation data from the remaining liquid amount is calculated as the remaining liquid amount and displayed in the input field A121.

  Here, when the co-infusion operation based on the preparation data is completed (S31: Yes), the control unit 41 receives information such as the remaining liquid amount registered in the remaining medicine management information manually by the operator. The case where registration is possible according to the operation has been described as an example. On the other hand, in the mixed injection operation, the chemical liquid extraction step of extracting the chemicals from the chemical containers for each of a plurality of types of chemicals may be performed. That is, a plurality of the chemical solution extraction steps may be sequentially performed, and a residual chemical may be generated in a plurality of chemical containers. In this case, the control unit 41 executes the manual registration process at each timing when the chemical liquid extraction process for each chemical is completed, and information such as the remaining liquid amount of the chemical that is the target of the chemical liquid extraction process. Can be registered in accordance with the manual operation by the operator. Moreover, the said control part 41 performs the said manual registration process at the timing when the said mixed injection operation | work was complete | finished, or the timing which all the said chemical | medical solution extraction processes were complete | finished, and information, such as the residual liquid amount of each chemical | medical agent, by an operator It may be possible to register together according to a manual operation.

[Form output function]
In general, for drugs such as anticancer drugs, the drug in one drug container is administered to one patient, and the drug in one drug container is not administered to a plurality of patients. On the other hand, as described above, in the configuration in which the remaining medicine in the medicine container generated in one mixed injection work can be used in another mixed injection work, the medicine in the same chemical container is used for a patient corresponding to a plurality of preparation data. Will be administered. Here, if any of the multiple patients to whom a drug has been administered suffers a health hazard, the same applies to other patients to whom the drug contained in the same drug container as that drug has been administered. May cause health problems. Therefore, it is conceivable that the control unit 41 has a form output function capable of outputting, as a form, a history of mixed injection work in which the chemical container is used for each chemical container based on the mixed injection work history data.

  Specifically, the control unit 41 includes identification information of each chemical container in the mixed injection work, use date and time, a collection amount from each of the chemical containers, contents of the preparation data, patient information of the preparation data, and information on the mixed injection work. Various kinds of information such as identification information of the preparer who is the worker are stored in the storage unit 413 as the history data of the mixed injection work. Note that the information stored as the history data is not limited to this as long as it is possible to specify the preparation data in which the same chemical container is used in the mixed injection operation.

  And the said control part 41 is based on the said log | history data of the mixed injection work performed in the specified specific period according to user operation, The mixed injection work performed using the said chemical | medical agent container for every said chemical | medical agent container A form P41 showing the history of the data is output by a method such as display output or print output. Specifically, based on the history data, the control unit 41 shows the history of the mixed injection work performed using the chemical container only for the chemical container used in the mixed injection operation based on the different preparation data. The form P41 is output.

  FIG. 28 is a diagram showing an example of a printed form P41. As shown in FIG. 28, in the form P41, for each medicine container, various information such as a management number of the medicine container, a medicine name, a use date, a collection amount, an order number, a patient name, and a preparation person are stored. It is shown. Thereby, it is possible to use the form P41 as it is as a confirmation form (multiple use confirmation form) for remaining medicine division use.

[Proficiency level reference distribution function]
Further, as described above, the distribution processing unit 211 can distribute each of the preparation data to the plurality of mixed injection working units based on the distribution condition. Here, as one example of the distribution condition, the distribution processing unit 211 converts each of the preparation data into the plurality of mixed injection work units based on the proficiency level of the mixed injection work of the worker who performs the work in the safety cabinet 2. It is conceivable to have a proficiency level reference distribution function. More specifically, the distribution processing unit 211 sets each of the preparation data based on the proficiency so that a difference in time required for the mixed injection work performed by each of the mixed injection work units is minimized. Distribution to the plurality of mixed injection working units is possible. The control unit 21 can switch the proficiency level reference distribution function between valid and invalid according to a user operation.

  Specifically, the control unit 21 can pre-register worker information indicating a worker who performs mixed injection work in the mixed injection operation unit such as the safety cabinet 2 according to a user operation, and the worker information is It is stored in the storage unit 22. Further, the control unit 21 may be able to set the worker information as the distribution condition. The worker information may be information included in the user master.

  Further, in the user master stored in the storage unit 22, the proficiency level of the pharmacist can be registered for each pharmacist who is the worker of the mixed injection work. In particular, it is conceivable that the control unit 21 automatically updates the proficiency level of each worker used as an index of the distribution condition according to the results of mixed injection work for each worker. The proficiency level is updated at a specific time set in advance such as a business start time or a business end time of a medical institution in which the mixed injection management system 1 is used. Thereby, the said proficiency level is appropriately updated according to the results of the mixed injection work for the worker, and the preparation data is appropriately distributed based on the proficiency level. The control unit 41 may arbitrarily change the proficiency level according to a user operation.

  For example, the control unit 21 counts the number of executions of the mixed injection work for each of the pharmacists, and automatically updates the proficiency level so that the proficiency level of the pharmacist increases as the number of executions increases. It is possible to have a learning function. More specifically, it is conceivable that the control unit 21 increases the proficiency level every time the number of implementations reaches a preset number. In addition, the said control part 21 can acquire the said implementation number by acquiring information, such as the historical data of the said mixed injection work by each said pharmacist, from the said mixed injection assistance apparatus 4. FIG.

  Moreover, the said control part 21 updates a proficiency level so that the said proficiency level becomes high, so that the average value of the time required for a co-infusion operation is low from the start time and the end time of the said co-infusion operation performed by each said pharmacist. Is also possible. Furthermore, the control unit 21 may update the proficiency level in consideration of the relationship between the difficulty of mixed injection work such as the number of used chemical containers or the number of needle sticks in the mixed injection work and the time required for the mixed injection work. . For example, even if the required time or the average value is the same, the control unit 21 may increase the proficiency level when the difficulty is high compared to when the difficulty is low. It is conceivable to update the proficiency level. The control unit 21 acquires information such as the average value of the time required for the mixed injection work by each pharmacist by acquiring information such as the history data of the mixed injection work by each of the pharmacists from the mixed injection support device 4. It is possible to know.

  Furthermore, the proficiency level of each pharmacist may be updated based on accuracy information that is an accuracy index such as a medicine authentication error, a weighing error, the number of imaging cancellations, and the number of NGs that have occurred in the mixed injection support process. Specifically, it is conceivable that the proficiency level is updated so that the proficiency level decreases as the chemical authentication error, the weighing error, the number of photographing cancellations, and the NG frequency increase. The number of NG times is, for example, the number of times that an audit result performed by an auditor other than the worker is NG. In addition, the said control part 21 can acquire the said accuracy information by each said pharmacist by acquiring information, such as the historical data of the said co-injection work by each said pharmacist, from the said co-infusion support apparatus 4. FIG.

  And the distribution process part 211 of the said control part 21 is based on the skill level of the operator registered into the said worker information as a worker who works in each said mixed injection work part, and several preparation data are made into several Allocate to the mixed injection working part. Specifically, based on the proficiency level, the distribution processing unit 211 sends the prepared data to the plurality of mixed injections so that the total time required for the mixed injection work in the plurality of mixed injection working units is as long as possible. It is conceivable to assign to the working part.

  For example, the proficiency level is a coefficient that is set in a stepwise manner within a preset range, and a standard mixed injection work time corresponding to each medicine or regimen is set in advance in the pharmaceutical master. The coefficient is a value that decreases as the proficiency level increases, and is divided into five levels: “1.0”, “1.2”, “1.4”, “1.6”, and “1.8”. It is possible that there is. Then, the distribution processing unit 211 is configured so that the total of the values obtained by multiplying the reference mixed injection work time corresponding to each medicine included in the prepared preparation data after the distribution by the proficiency is the same as possible. Can be considered. Thereby, based on the proficiency level, a plurality of preparation data is sent to the plurality of mixed injection work units so that the total time required for the mixed injection work in the plurality of mixed injection work units is as long as possible. It becomes possible to distribute.

  In the mixed injection management device 2, the control unit 21 selects an arbitrary distribution mode from a plurality of distribution modes set in advance as a distribution operation mode for distributing the preparation data in accordance with a user operation. Thus, it is possible that the distribution can be executed. Specifically, here, as the distribution mode, a case where three kinds of distribution modes of order order distribution mode, medicine saving distribution mode, and AI distribution mode can be selected will be described as an example. .

  The order order distribution mode is a mode in which a plurality of the preparation data are sequentially distributed to the plurality of mixed injection working units in the order of input of the preparation data (order order). That is, in the order sequential distribution mode, the preparation data is distributed so that the number of times of the mixed injection work in each of the mixed injection work units is substantially the same.

  The medicine saving distribution mode is a mode in which a plurality of the preparation data is distributed to a plurality of the mixed injection work sections so that the remaining medicine generated in the mixed injection work can be used as much as possible. For example, in the medicine saving distribution mode, a plurality of the preparation data is transferred to a plurality of the mixture injection work sections so that the mixture injection work based on the preparation data in which the same medicine is used is performed in the same mixture injection work section. Sorted.

  The AI distribution mode is a mode in which a plurality of the preparation data is distributed to a plurality of the mixed injection work units so that a total time of the mixed injection work required in the plurality of the mixed injection work units is as long as possible. . In other words, in the AI distribution mode, a plurality of the prepared data are distributed to the plurality of mixed injection work units so that the time required until the mixed injection work in all the mixed injection work units is completed is minimized. Mode. For example, in the AI distribution mode, the sum of values obtained by multiplying the reference mixed injection operation time corresponding to each medicine included in the prepared data after distribution by the proficiency is the same as possible (difference) in each of the mixed injection operation units. A plurality of the preparation data are distributed to a plurality of the mixed injection working sections. In addition, the AI distribution mode is a highly difficult mixed injection operation such as preparation data in which a mixed injection operation using a residual drug among a plurality of the preparation data is performed and preparation data in which a residual drug is generated in the mixed injection operation. The mode in which the preparation data is distributed to the mixed injection work unit that is handled by an operator with a high level of proficiency may be used.

  By the way, the distribution processing unit 211 of the control unit 21 may include a simulation function for simulating the preparation time and the drug price based on the distribution result of each of the preparation data based on the distribution operation mode. Specifically, the control unit 21 selects preparation data to be distributed among the preparation data to be processed in any one or a plurality of periods of the past, the current, and the future in response to a user operation. In addition, the distribution processing unit 211 can set the distribution conditions such as the number of the mixed injection work units, the number of the automatic mixed injection devices 5, and the presence / absence of use of the remaining medicine according to the user operation. Then, the distribution processing unit 211 distributes the preparation data based on the distribution conditions for the preparation data selected as the distribution target.

  Thereafter, the presentation processing unit 212 of the control unit 21 calculates a preparation time, a medicine price, and the like based on the distribution result of each of the preparation data, and displays the simulation result on the display unit 24 or the display unit 34. Or print out using a printer connected to the communication network N1. FIG. 29 is a diagram showing a display example of the simulation result output screen P51. As shown in FIG. 29, the output screen P51 displays the period of the preparation data selected as a distribution target, the number of prescriptions indicating the number of preparation data, and the time required for the simulation process.

  In addition, in the output screen P51, “number of medicines to be dispensed” indicating the total number of times of chemical co-infusion in the co-infusion operation based on a plurality of the preparation data selected as distribution targets, and “chemicals in use” indicating the number of chemical containers used. Number ”,“ Payment drug price ”indicating the total price of the drug corresponding to the number of drugs to be dispensed,“ Used drug price ”indicating the total price of the drug corresponding to the number of drugs used, the price of the drug to be dispensed and the use “Differential price” indicating the difference in drug prices is displayed. In the mixed injection management system 1, when the remaining medicine generated in the preceding mixed injection work is used in the subsequent mixed injection work, the differential price may be suppressed, and the number of times the remaining medicine is used increases. As a result, the differential price increases.

  Furthermore, in the output screen P51, information on the required time is displayed when the mixed injection work based on the plurality of preparation data selected as the distribution target is executed. Specifically, “preparation time (shortest day)” indicating the required time on the day when the required time is the shortest during the period of the preparation data to be distributed, between the period of the preparation data “Preparation time (maximum daily)” indicating the required time on the day when the required time becomes the longest, and “preparation time (1 day) indicating the average of the required time per day during the preparation data period” Average) ”is displayed. In the mixed injection management system 1, when the residual medicine generated in the preceding mixed injection work is used in the subsequent mixed injection work, the differential price may be suppressed, and as the number of use of the residual medicine increases, The differential price will increase.

  As described above, if the output screen P51 is configured to be output, the worker refers to the output screen P51 to select a distribution operation mode in which a desired effect can be obtained from the plurality of distribution operation modes. Judgment can be easily made. The output screen P51 displays a display area A151 including a plurality of operation keys for selecting the sorting operation mode when sorting the prepared data. And the said control part 21 can set the said distribution operation mode at the time of distributing the said preparation data according to user operation of the said display area A151 in the said output screen P51. The control unit 21 can change the period of the preparation data to be subjected to the simulation process on the output screen P51 according to a user operation, and can execute the simulation process based on the changed period. Also good. In addition, although the case where the simulation result in the case of distribution in each of the distribution operation modes is output at the same time has been described here, only the simulation result in the case of distribution in the pre-selected distribution operation mode may be output. good.

  In addition, as described above, the distribution processing unit 211 uses the first mixed injection operation to prepare the preparation data relating to the second mixed injection operation using the same type of chemical as the remaining chemical generated in the preceding first mixed injection operation. Can be preferentially distributed to the same mixed injection work section. On the other hand, for example, when it is set in the mixed injection management system 1 that the remaining medicine is not used, the distribution processing 211 executes the preparation data distribution processing in consideration of the proficiency level. . Similarly, when the mixed injection management system 1 is a system in which the remaining medicine generated in the preceding first mixed injection operation cannot be used in the second mixed injection operation executed thereafter, the distribution processing unit 211 The preparation data distribution process may be executed in consideration of the proficiency level.

  Moreover, in the said mixed injection management system 1 which concerns on this embodiment, distribution of the preparation data used as the object of the mixed injection operation performed using a syringe was demonstrated. On the other hand, it is also conceivable to distribute prescription data or dispensing data, which is a target of dispensing work such as picking work or weighing work performed without using a syringe, according to the level of proficiency of the worker.

  By the way, in the mixed injection management system 1, the preparation data to be subjected to the mixed injection work in the mixed injection support device 4 or the automatic mixed injection device 5 can be arbitrarily selected in the mixed injection support device 4 or the automatic mixed injection device 5. It may be. In this case, for example, the operator selects the preparation data to be subjected to the mixed injection work in the mixed injection support device 4 or the automatic mixed injection device 5 while referring to the printed matter of the distribution result presented by the presentation processing unit 212. Thus, the mixed injection work can be performed. However, the distribution processing unit 211 selects the preparation data by the mixed injection support device 4 or the automatic mixed injection device 5 corresponding to each of the mixed injection work units according to the distribution result by the distribution processing unit 211, You may limit to the said preparation data distributed to the mixed injection operation part. That is, when the preparation data is selected by the mixed injection work unit, the distribution processing unit 211 displays a message indicating that the preparation data is not distributed to the mixed injection operation unit. It is conceivable to prohibit the selection of the preparation data.

  On the other hand, according to the distribution result by the distribution processing unit 211, the distribution processing unit 211 corresponds to the mixed injection support unit 4 or the automatic mixed injection device corresponding to the mixed injection work unit to which each of the preparation data is distributed. 5 may be transmitted as preparation data to be subjected to the mixed injection work in the mixed injection work unit. Thereby, the operator can execute only the mixed injection work for the preparation data distributed to the mixed injection support device 4 in order using the mixed injection support device 4. Further, the automatic co-infusion apparatus 5 can automatically execute the co-infusion operation in order based on the distribution result.

  By the way, also in the automatic co-infusion apparatus 5, as in the co-infusion operation performed in the safety cabinet 100, the second chemical that uses the same type of chemical as the residual chemical is used as the residual chemical generated in the preceding first automatic co-infusion process. It can be used in the automatic mixed injection process. In this case, in the automatic co-infusion apparatus 5, the medicine container in which the remaining medicine is accommodated is stored on the storage shelf or the like in the automatic co-infusion apparatus 5 until the next use. Incidentally, the co-infusion processing chamber 203 of the automatic co-infusion apparatus 5 is provided with an illuminating device such as a fluorescent lamp for illuminating the inside of the co-infusion processing chamber 203, and the control unit 51 turns on and off the illumination device. Can be controlled. For example, the control unit 51 may turn on the lighting device when the automatic co-infusion process is executed by the automatic co-infusion apparatus 5 or when the automatic co-infusion apparatus 5 is powered on. On the other hand, when a chemical container storing the residual drug is stored in the mixed injection processing chamber 203, the residual drug may be a light shielding target drug such as an anticancer drug (for example, dacarbacin) that requires light shielding. It is done. However, if the illuminating device in the mixed injection processing chamber 203 is in a lighting state, it is not possible to store the light shielding target drug in the mixed injection processing chamber 203 as the remaining chemical and use it in the subsequent automatic mixed injection processing. Therefore, when the remaining medicine stored in the medicine container stored in the mixed injection processing chamber 203 is a light shielding target medicine, the control unit 51 waits until the remaining medicine is used or It is conceivable to turn off the lighting device until the chemical container is discarded. Thereby, even if the remaining medicine is a light shielding target medicine, the remaining medicine can be used in the subsequent automatic co-infusion processing. In particular, when the drug to be shielded from light is stored in the storage shelf in a state where it is accommodated in a syringe or the like that does not have light shielding properties, the lighting device is preferably turned off. In addition, the lighting device may be controlled to be turned off while the light shielding target chemical is stored in the mixed injection processing chamber 203 without being limited to the remaining chemical. Note that if the lighting device in the mixed injection processing chamber 203 is turned off during the automatic mixed injection processing, the camera provided in the mixed injection processing chamber 203 may have a problem in photographing. May be an infrared camera, or the control unit 51 may turn on the lighting device only when photographing with the camera.

  Further, after the injection step of injecting the medicine in the syringe into the infusion bag in the automatic co-infusion apparatus 5, the medicine or the infusion liquid may adhere to the mouth portion of the infusion bag. Therefore, after the injection step, the control unit 51 controls the first robot arm 551 or the second robot arm 552, and the infusion solution is wiped with a wiping member such as a cotton ball in which a disinfectant solution such as alcohol has penetrated. It is conceivable to execute a wiping process of wiping the mouth of the bag. In this case, when the automatic co-infusion process is executed by the automatic co-infusion apparatus 5, a tray on which the wiping member is placed is set by the user together with a medicine container, an infusion bag, a syringe, and the like used in the automatic co-infusion process. Loaded. However, if the wiping member is placed on the tray with the wiping member exposed, the automatic co-infusion process using the tray is not executed immediately after the tray is loaded in the automatic co-infusion apparatus 5. In this case, there is a possibility that the disinfecting liquid permeating the wiping member may be dried and reduced before the wiping member is used. Therefore, when the wiping member is placed on the tray, it is conceivable that the wiping member is placed on the tray in a state of being housed in a sealed container. Then, the control unit 51 controls the first robot arm 551 or the second robot arm 552 to open the sealed container when the automatic co-infusion process is executed, and stores the sealed container in the sealed container. It is conceivable that the wiping member that has been removed is taken out and the wiping step is executed. The method for opening the sealed container by the first robot arm 551 or the second robot arm 552 is not particularly limited. For example, either the first robot arm 551 or the second robot arm 552 is used for the sealing. It is conceivable that the container is held, and a part of the sealed container (lid member such as a sealing film) is peeled off by the other, so that the wiping step is exposed and can be taken out. Further, for example, the sealed container is held by one of the first robot arm 551 and the second robot arm 552, and the other part of the sealed container (a cover member such as a sealing film) is broken by the other. It is conceivable that the wiping member is exposed and can be taken out. Note that the object to be wiped by the wiping member is not limited to the infusion bag, and the same applies to a case where, for example, a wiping process in which the mouth portion of the chemical container is wiped by the wiping member is executed.

[Additional Notes]
Hereinafter, the technical idea of the invention extracted from the above-described embodiment will be additionally described. Moreover, it is also possible to select and arbitrarily combine each configuration and each processing function to be described below.

<Appendix 1>
A distribution processing unit that distributes a plurality of preparation data relating to a mixed injection operation for collecting and injecting a medicine into an infusion container to a plurality of mixed injection operation units in which the mixed injection operation is performed based on a remaining chemical generated in the preceding mixed injection operation When,
A presentation processing unit for presenting information on a distribution result by the distribution processing unit;
A mixed injection management system.

<Appendix 2>
The distribution processing unit prioritizes preparation data relating to the second mixed injection operation using the same type of chemical as the remaining chemical generated in the preceding first mixed injection operation to the same mixed injection operation unit as the first mixed injection operation. Sort out,
The mixed injection management system according to attachment 1.

<Appendix 3>
The distribution processing unit distributes each of the preparation data to the plurality of mixed injection working units based on predetermined distribution conditions in addition to the remaining medicine.
The mixed injection management system according to Supplementary Note 1 or Supplementary Note 2.

<Appendix 4>
The sorting conditions include the time of execution of the mixed injection operation corresponding to each of the preparation data, the administration time of the medicine collected in the mixed injection operation, the operation time required for the mixed injection operation, the time of the medicine from the chemical container in the mixed injection operation Number of collections, presence / absence of use of the remaining drug in the mixed injection operation, type of drug extracted in the mixed injection operation, drug price of the drug extracted in the mixed injection operation, closed drug transfer system used in the mixed injection operation Including a condition relating to at least one of a price and a usable period of the remaining medicine generated in the mixed injection operation,
The mixed injection management system according to appendix 3.

<Appendix 5>
The allocation processing unit can distribute each of the preparation data to the plurality of mixed injection work units so that the cost required for the mixed injection operation corresponding to the plurality of preparation data is minimized.
The mixed injection management system according to any one of appendices 1 to 4.

<Appendix 6>
The allocation condition includes a proficiency level of an operator who performs the mixed injection work in each of the mixed injection work units.
The mixed injection management system according to appendix 3 or 4.

<Appendix 7>
The allocation processing unit is configured to minimize a difference in time required for the mixed injection work performed in each of the mixed injection work units based on a proficiency level of an operator who performs the mixed injection operation in each of the mixed injection operation units. In addition, each of the preparation data can be distributed to the plurality of mixed injection working units,
The mixed injection management system according to appendix 6.

<Appendix 8>
The distribution processing unit is capable of distributing each of the preparation data to the plurality of mixed injection work units so that the number of times of drug collection from the chemical container in the mixed injection operation corresponding to the plurality of preparation data is minimized. ,
The mixed injection management system according to any one of appendices 1 to 7.

<Appendix 9>
The sorting processing unit includes one or a plurality of preparation data corresponding to the mixed injection operation in which the remaining medicine is generated and one or a plurality of preparation data corresponding to the mixed injection operation using the remaining medicine as one preparation data group. A grouping process for grouping, a first distribution process for distributing the preparation data belonging to the preparation data group to the plurality of mixed injection working units in units of the preparation data group, and the preparation data group after the first distribution process Performing a second distribution process of distributing the preparation data not belonging to the plurality of mixed injection working units,
The mixed injection management system according to any one of appendices 1 to 8.

<Appendix 10>
When the remaining medicine that can be used in the mixed injection operation is present, a display screen that allows selection of whether or not to use the remaining medicine is displayed, and the use of the remaining medicine according to a user operation on the display screen. A selection processing unit capable of selecting presence or absence;
The mixed injection management system according to any one of appendices 1 to 9.

<Appendix 11>
The selection processing unit can display information on the amount of work when using the remaining medicine and when not using the information or information suggesting a difference in the amount of work on the display screen.
The mixed injection management system according to attachment 10.

<Appendix 12>
A storage processing unit that stores residual medicine management information including the amount of residual medicine remaining in the mixed injection operation in a storage unit;
A determination processing unit that determines whether or not there is a residual drug that can be used in the mixed injection operation based on the residual drug management information stored in the storage unit;
A registration processing unit capable of registering the amount of the remaining medicine in the remaining medicine management information according to a user operation;
A mixed injection management system according to any one of appendices 1 to 11, comprising:

<Appendix 13>
The plurality of mixed injection work units include one or more manual operation units in which the mixed injection operation is performed by a person and one or more automatic operation units in which the mixed injection operation is performed by a robot.
The distribution processing unit preferentially distributes the preparation data that matches the automatic operation condition indicating the condition to be distributed to the automatic operation unit to the automatic operation unit,
The mixed injection management system according to any one of appendices 1 to 12.

<Appendix 14>
The plurality of mixed injection work units include one or more manual operation units in which the mixed injection operation is performed by a person and one or more automatic operation units in which the mixed injection operation is performed by a robot.
The distribution processing unit preferentially distributes the preparation data that matches the manual operation condition indicating the condition to be distributed to the manual operation unit to the manual operation unit,
The mixed injection management system according to any one of supplementary notes 1 to 13.

<Appendix 15>
The presentation processing unit, for the preparation data distributed by the distribution processing unit, the preparation data corresponding to the mixed injection work in which the remaining medicine is generated and the preparation data corresponding to the mixed injection work in which the residual drug is not generated Present it in a discriminable way
The mixed injection management system according to any one of appendices 1-14.

<Appendix 16>
The presentation processing unit includes preparation data corresponding to the mixed injection work using the remaining chemical generated in the preceding mixed injection work and the remaining chemical generated in the preceding mixed injection work with respect to the preparation data distributed by the distribution processing unit. Presenting the preparation data corresponding to the mixed injection work without using
The mixed injection management system according to any one of supplementary notes 1 to 15.

<Appendix 17>
The presentation processing unit is the difference between the total amount of medicine required when the remaining medicine is used according to the distribution result by the distribution processing section and the total amount of medicine required when the remaining medicine is not used. Can be presented,
The mixed injection management system according to any one of appendices 1 to 16.

<Appendix 18>
The presentation processing unit is capable of presenting an amount corresponding to a residual drug that is ultimately wasted when a mixed injection operation corresponding to the plurality of preparation data is performed according to a distribution result by the distribution processing unit.
The mixed injection management system according to any one of appendices 1 to 17.

<Appendix 19>
Remaining amount calculation for calculating the remaining amount of the remaining medicine generated in the mixed injection work corresponding to the preparation data based on the amount of the medicine indicated in the preparation data and the predetermined amount of the medicine container in which the medicine is accommodated. A processing unit;
Based on the calculation result of the remaining amount calculation processing unit, further comprising a management processing unit for managing the type and remaining amount of the remaining drug remaining in one or a plurality of drug containers in each of the mixed injection work units,
The presenting processing unit can present the remaining amount for each medicine at the present time based on the information on the type and remaining amount of the remaining medicine managed by the management processing unit,
The mixed injection management system according to any one of appendices 1 to 18.

<Appendix 20>
One or more processors,
A distribution step of allocating a plurality of preparation data relating to a mixed injection operation for collecting and injecting a medicine into an infusion container to a plurality of mixed injection operation units in which the mixed injection operation is performed based on a residual drug generated in the preceding mixed injection operation; ,
A presenting step for presenting information on a sorting result in the sorting step;
A mixed injection management program to execute.

<Appendix 21>
A distribution step of allocating a plurality of preparation data relating to a mixed injection operation for collecting and injecting a medicine into an infusion container to a plurality of mixed injection operation units in which the mixed injection operation is performed based on a residual drug generated in the preceding mixed injection operation; ,
A presenting step for presenting information on a sorting result in the sorting step;
Mixed injection management method.

DESCRIPTION OF SYMBOLS 1 Mixed injection management system 2 Mixed injection management apparatus 21 Control part 211 Distribution processing part 212 Presentation processing part 213 Remaining amount calculation processing part 214 Remaining amount management processing part 3 Client terminal 4 Mixed injection support apparatus 5 Automatic mixed injection apparatus 100 Safety cabinet 101 Work room 203 Mixed injection processing room

Claims (14)

Distributing a plurality of preparation data related to mixed injection work for collecting medicines and injecting them into an infusion container to a plurality of mixed injection work parts where the mixed injection work is performed based on information on residual chemicals generated in the preceding mixed injection work A processing unit;
A presentation processing unit for presenting information on a distribution result by the distribution processing unit;
A mixed injection management system. The distribution processing unit prioritizes preparation data relating to the second mixed injection operation using the same type of chemical as the remaining chemical generated in the preceding first mixed injection operation to the same mixed injection operation unit as the first mixed injection operation. Sort out,
The mixed injection management system according to claim 1. The distribution processing unit distributes each of the preparation data to the plurality of mixed injection working units based on predetermined distribution conditions in addition to the remaining medicine.
The mixed injection management system according to claim 1 or 2. The sorting conditions include the time of execution of the mixed injection operation corresponding to each of the preparation data, the administration time of the medicine collected in the mixed injection operation, the operation time required for the mixed injection operation, the time of the medicine from the chemical container in the mixed injection operation Number of collections, presence / absence of use of the remaining drug in the mixed injection operation, type of drug extracted in the mixed injection operation, drug price of the drug extracted in the mixed injection operation, closed drug transfer system used in the mixed injection operation Including a condition relating to at least one of a price and a usable period of the remaining medicine generated in the mixed injection operation,
The mixed injection management system according to claim 3. The allocation processing unit can distribute each of the preparation data to the plurality of mixed injection work units so that the cost required for the mixed injection operation corresponding to the plurality of preparation data is minimized.
The mixed injection management system according to any one of claims 1 to 4. The allocation condition includes a proficiency level of an operator who performs the mixed injection work in each of the mixed injection work units.
The mixed injection management system according to claim 3 or 4. The allocation processing unit is configured to minimize a difference in time required for the mixed injection work performed in each of the mixed injection work units based on a proficiency level of an operator who performs the mixed injection operation in each of the mixed injection operation units. In addition, each of the preparation data can be distributed to the plurality of mixed injection working units,
The mixed injection management system according to claim 6. The presentation processing unit, for the preparation data distributed by the distribution processing unit, the preparation data corresponding to the mixed injection work in which the remaining medicine is generated and the preparation data corresponding to the mixed injection work in which the residual drug is not generated Present it in a discriminable way
The mixed injection management system according to any one of claims 1 to 7. The presentation processing unit is the difference between the total amount of medicine required when the remaining medicine is used according to the distribution result by the distribution processing section and the total amount of medicine required when the remaining medicine is not used. Can be presented,
The mixed injection management system according to any one of claims 1 to 8. When the remaining medicine that can be used in the mixed injection operation is present, a display screen that allows selection of whether or not to use the remaining medicine is displayed, and the use of the remaining medicine according to a user operation on the display screen. A selection processing unit capable of selecting presence or absence;
The mixed injection management system according to any one of claims 1 to 9. The selection processing unit can display information on the amount of work when using the remaining medicine and when not using the information or information suggesting a difference in the amount of work on the display screen.
The mixed injection management system according to claim 10. A storage processing unit that stores residual medicine management information including the amount of residual medicine remaining in the mixed injection operation in a storage unit;
A determination processing unit that determines whether or not there is a residual drug that can be used in the mixed injection operation based on the residual drug management information stored in the storage unit;
A registration processing unit capable of registering the amount of the remaining medicine in the remaining medicine management information according to a user operation;
The mixed injection management system according to claim 1, comprising: One or more processors,
Distributing a plurality of preparation data related to mixed injection work for collecting medicines and injecting them into an infusion container to a plurality of mixed injection work parts where the mixed injection work is performed based on information on residual chemicals generated in the preceding mixed injection work Steps,
A presenting step for presenting information on a sorting result in the sorting step;
A mixed injection management program to execute. Distributing a plurality of preparation data related to mixed injection work for collecting medicines and injecting them into an infusion container to a plurality of mixed injection work parts where the mixed injection work is performed based on information on residual chemicals generated in the preceding mixed injection work Steps,
A presenting step for presenting information on a sorting result in the sorting step;
Mixed injection management method.